Schedule 13D/13G 大股东持股申报追踪

任何投资人取得上市公司5%以上股权，都必须通过 Schedule 13D（具主动或控制意图，通常是激进投资人）或 13G（被动投资）披露——这往往是大股东动向最早的信号。

申报数 (30天)

2445

涉及公司数

1597

具明确激进意图

257

排行榜申报数

数据更新至 2026-09-04

最活跃个股 (30天)

代码	公司名称	申报数	最新激进意图声明	最后申报
VBIO	Valion Bio, Inc.	8	This Item 4 is not being amended by this Amendment No. 7.	2026-09-04
ENHA	Enhanced Group Inc. (f/k/a A Paradise Acquisition Corp.)	8	Purchase Agreement. On June 14, 2026, the Issuer entered into the Purchase Agreement pursuant to which the Issuer agreed to issue and sell to the Reporting Person: (A) 1,285,347 shares of Class A Common Stock and (B) accompanying warrants to purchase 1,285,347 shares of Class A Common Stock (the "Warrants"). The Class A Common Stock and accompanying Warrants were issued separately. The combined purchase price per share of Class A Common Stock and accompanying Warrant was $3.89. The Private Placement closed on August 14, 2026, after the effectiveness of the Stockholder Consent (as defined in the Purchase Agreement). Registration Rights Agreement. On June 14, 2026, the Issuer also entered into a registration rights agreement with the Reporting Person (the "Registration Rights Agreement"), pursuant to which the Issuer has agreed to file a registration statement under the Securities Act with the SEC, covering the resale of the Class A Common Stock and the shares of Class A Common Stock underlying the Warrants no later than 30 days following the applicable closing date and to use commercially reasonable efforts to have the registration statement declared effective by the SEC at the earliest possible date but no later than the earlier of the 90th calendar day following the initial filing date of the registration statement, if the SEC notifies the Company that it will "review" the registration statement, and the fifth business day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that the registration statement will not be "reviewed" or will not be subject to further review. The foregoing description of the Purchase Agreement, the Warrants and the Registration Rights Agreement do not purport to be complete and are each qualified in their entirety by the full text of the form of such agreements, which are attached as exhibits to this Schedule 13D and incorporated herein by reference	2026-08-20
BETR	Better Home & Finance Holding Company	6	This Amendment No. 7 hereby amends and supplements Item 4 of the Schedule 13D by adding the following thereto: "On August 17, 2026, Vishal Garg and affiliated entities (the "Garg Group") filed with the SEC a preliminary consent statement on Schedule 14A, as amended by Amendment No. 1 thereto filed August 18, 2026 and Amendment No. 2 thereto filed August 25, 2026. Such consent statement states that the Garg Group is soliciting consents of the Issuer's stockholders for, among other things, the proposed removal without cause of the incumbent Issuer directors named therein. Such consent statement also states, among other things, that the previous written stockholder consents delivered to the Issuer on August 17, 2026 in connection with the proposed removal of such directors did not constitute a majority of the Issuer's voting power; and that the only consents that will be solicited by the Garg Group for the proposals described in such consent statement will be by way of such consent statement. The Reporting Persons are not affiliated with, and no Reporting Person is a participant in the consent solicitation being conducted by, the Garg Group. The Reporting Persons currently intend, at the appropriate time pursuant to such consent solicitation, to provide their consent to the removal of the directors named therein. The Reporting Persons acquired the Issuer securities reported herein for investment purposes. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending upon various factors, including, without limitation, the Issuer's financial position and strategic direction, developments concerning the Issuer's corporate governance arrangements, overall market, economic, and industry conditions, the trading price of the Issuer's securities, other investment opportunities available to the Reporting Persons, and the liquidity requirements of the Reporting Persons, the Reporting Persons may seek to increase or decrease their holdings of or their economic exposure to the securities of the Issuer. The Reporting Persons may communicate with other stockholders of the Issuer, directors or officers of the Issuer, and/or other persons regarding the Issuer's business, strategy, operations, management, corporate governance, financial position, and other matters concerning the Issuer. Except to the extent the foregoing may be deemed a plan or proposal, none of the Reporting Persons has any plans or proposals which relate to, or could result in, any of the matters referred to in subparagraphs (a) - (j) of Item 4 of Schedule 13D. The Reporting Persons may, at any time and from time to time, review or reconsider their position and/or change their purpose and/or formulate plans or proposals with respect thereto, and/or consider or propose one or more of the actions described in subparagraphs (a) - (j) of Item 4 of Schedule 13D."	2026-08-25
GNK	GENCO SHIPPING & TRADING LTD	5	Item 4 of the Current Schedule 13D is hereby amended and supplemented to add the following: On August 14, 2026, Diana issued a press release announcing that Diana has withdrawn its proposal submitted to the board of directors of the Issuer on June 17, 2026 to acquire all of the issued and outstanding Shares of the Issuer not already owned by Diana for $24.80 in cash (adjusted for the Issuer's recently declared dividend of $0.80 per Share) plus one share of stock of Diana valued at $2.54 based on Diana's 30-day volume-weighted average price as of June 16, 2026 (the "Offer"). Notwithstanding the withdrawal of the Offer, Diana intends to regularly review its investment in the Issuer and consider all potential courses of action in connection with the Issuer and its Shares. Based on such review, as well as other factors, Diana may from time to time and at any time: (i) acquire additional Shares of the Issuer in the open market, in privately negotiated transactions or otherwise; (ii) dispose of any or all of their Shares in the open market, in privately negotiated transactions or otherwise; and (iii) engage in any hedging or similar transactions with respect to the Shares. Any such actions that Diana might undertake may be made at any time without prior notice based on, among other things, Diana's review of numerous factors, including, but not limited to: an ongoing evaluation of the Issuer's business, financial condition, operations and prospects; price levels of the Issuer's Shares; general market, industry and economic conditions; the relative attractiveness of alternative business and investment opportunities available to Diana; and other future developments. Further, Diana may, and reserves the right to, formulate plans or make proposals that could relate to or result in any of the matters listed in Items 4(a) - (j) of Schedule 13D, modify or withdraw any such plan or proposal, or change its intentions with respect to previous plans or proposals, in each case at any time.	2026-08-27
SLMT	Brera Holdings PLC	4	Item 4 is hereby amended and restated to read as follows: The information set forth or incorporated in Item 3 is hereby incorporated by reference. On the Event Date, Mr. Sade, Ms. Maimon, Ms. Almheiri and Mr. Alnuaimi were appointed to the Board of Directors of the Issuer (the "New Directors"). As directors of the Issuer, each of the New Directors may be able to control the Issuer's business and influence the corporate activities of the Issuer, and expects in the future to discuss and make decisions in the ordinary course of his or her duties regarding plans or proposals with respect to the transactions described in clauses (a) through (j) of Item 4 of Schedule 13D. Depending on the factors discussed herein, each of the New Directors may, from time to time, in their individual capacities, acquire additional Ordinary Shares and/or retain and/or sell all or a portion of the Ordinary Shares held by such person in the open market or in privately negotiated transactions, and/or may distribute Ordinary Shares to be acquired or held by such person to other entities. Any actions that each of the New Directors might undertake will be dependent upon such person's review of numerous factors, including, among other things, the price levels of the Ordinary Shares, general market and economic conditions, ongoing evaluation of the Issuer's business, financial condition, operations and prospects, the relative attractiveness of alternative business and investment opportunities, such person's need for liquidity, and other future developments. Any future acquisitions of Ordinary Shares by each of the New Directors will be subject to the Issuer's policies, including its insider trading policy, as applicable. On the Event Date in connection with the PIPE and the related transactions, the Reporting Persons mutually agreed to dissolve and terminate their informal understanding to act as a "group" for purposes of Regulation 13D solely with respect to the Ordinary Shares of the Issuer. In connection with such determination, each of the Reporting Persons acknowledged and agreed that they are no longer members of a "group" within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Accordingly, effective as of the Event Date, the Reporting Persons no longer may be deemed a "group" within the meaning of Section 13(d)(3) of the Exchange Act and each of Mr. Hirsch, Mr. Sade, Mr. Haklili, Ms. Maimon, Ms. Almheiri and Mr. Alnuaimi separately beneficially owns less than 5% of the outstanding Ordinary Shares of the Issuer and shall cease to be Reporting Persons immediately after the filing of this Amendment. As a result of the Reporting Persons' termination of their informal understanding to act as a "group", except as set forth herein with respect to the New Directors and the Strategic Advisors, none of the Reporting Persons presently has any additional plans or proposals that relate to or that would result in any of the transactions or other matters specified in clauses (a) through (j) of Item 4 of Schedule 13D, but depending on the factors discussed herein, the Reporting Persons may change their purpose or formulate different plans or proposals with respect their investment in the Issuer at any time.	2026-08-21
GRNT	Granite Ridge Resources, Inc.	4	Item 4 of the Schedule 13D is hereby amended and supplemented as provided below. Distribution On August 19, 2026, the Fund III Filing Parties effected a pro rata distribution of an aggregate of 14,000,000 shares of Common Stock to their respective limited partners and members, consisting of 4,247,600 shares distributed by Holdco III-A and 9,752,400 shares distributed by Holdco III-B. Voting Agreement On August 25, 2023, GREP GP III (who had voting and dispositive power over Common Stock owned by Fund III and certain of its affiliates), GREP GP II (who had voting and dispositive power over Common Stock owned by Fund II and certain of its affiliates), and Matthew Miller, Griffin Perry, Thaddeus Darden and Kirk Lazarine (collectively, the "Voting Agreement Parties") entered into a Stockholder Voting Agreement (the "Voting Agreement"). Pursuant to the Voting Agreement, the Voting Agreement Parties irrevocably and unconditionally agreed to vote the 75,957,927 shares of Common Stock which the Voting Agreement Parties then held (and any other shares of Common Stock obtained by Voting Agreement Parties in the future) at any annual or special meeting of the Company's stockholders or in connection with any written consent of the Company's stockholders. During the period it was in effect, the Voting Agreement continued indefinitely, but could be terminated on 30 days prior written notice by Voting Agreement Parties holding a majority of the shares of Common Stock subject to the Voting Agreement. In connection with their entry into the Voting Agreement, the Voting Agreement Parties provided GREP GP III an irrevocable voting proxy to vote the shares subject to the Voting Agreement. Additionally, during the term of such agreement, the Voting Agreement Parties agreed not to transfer the shares covered by the Voting Agreement without the consent of GREP GP III, except pursuant to certain limited exceptions. The description of the Voting Agreement contained in this Item 4 is not intended to be complete and is qualified in its entirety by reference to such agreement, which is filed as an exhibit hereto and incorporated by reference herein. Termination of Voting Agreement Effective August 19, 2026, the Voting Agreement Parties terminated the Stockholder Voting Agreement dated August 25, 2023, and it is no longer in effect. As a result, the irrevocable proxy in favor of GREP GP III and the transfer restrictions thereunder have terminated. Open Market Acquisitions and Vesting of Restricted Stock On September 18, 2023, the following Filing Parties made open market acquisitions of shares of Common Stock: Matthew Miller acquired 17,284 shares at prices ranging from $5.73 to $5.85 per share; Griffin Perry acquired 2,000 shares at a price of $5.76 per share, Thaddeus Darden acquired 20,000 shares at a price of $5.74 per share, and Kirk Lazarine acquired 10,000 shares at a price of $5.75 per share. On November 30, 2023, Thaddeus Darden acquired 10,000 shares at a price of $5.92 per share. On December 4, 2023, the following Filing Parties made open market acquisitions of shares of Common Stock: Griffin Perry acquired 3,000 shares at a price of $5.89 per share, and Thaddeus Darden acquired 10,000 shares at a price of $5.80 per share. On December 12, 2023, Matthew Miller acquired 2,600 shares at a price of $5.93 per share. On January 3, 2024, pursuant to an award of restricted stock granted to each of the Company's director under the Company's 2022 Omnibus Incentive Plan, 8,813 shares of restricted Common Stock issued to each of Matthew Miller, Griffin Perry, Thaddeus Darden, and Kirk Lazarine vested. On March 14, 2025 and March 15, 2024, Matthew Miller acquired a total of 4,900 shares at prices ranging from $6.20 to $6.22 per share. On May 23, 2024, Griffin Perry acquired 2,000 shares at a price of $6.54 per share. On June 3, 2024 through June 17, 2024, Matthew Miller acquired a total of 16,683 shares at prices ranging from $5.90 to $6.50 per share. On June 6, 2024, Thaddeus Darden acquired 3,000 shares at a price of $6.29. On June 14, 2024, Thaddeus Darden acquired 7,000 shares at a price of $5.90 per share. On August 16, 2024, Matthew Miller acquired 4,938 shares at a price of $6.50 per share. On August 22, 2024, Matthew Miller acquired 4,000 shares at a price of $6,33 per share. On September 11, 2024, Matthew Miller acquired 8,500 shares at a price of $5.97 per share. On September 13, 2024, Matthew Miller acquired 495 shares at a price of $6.23 per share. On September 12, 2024, Griffin Perry acquired 5,000 shares at a price of $6.13 per share. On November 20, 2024, Matthew Miller acquired 18,173 shares at prices ranging from $6.47 to $6.53 per share. On November 21, 2024, Matthew Miller acquired 20,327 shares at prices ranging from $6.59 to $6.63 per share. On December 6, 2024, the following Filing Parties made open market acquisitions of shares of Common Stock: Thaddeus Darden acquired 9,440 shares at prices ranging from $6.10 to $6.13 per share. Matthew Miller acquired 31,000 shares at prices ranging from $6.05 to $6.12 per share. Except as set forth in this Schedule 13D, the Filing Parties do not have any plan or proposal that would relate to, or result in, any of the following matters: (a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the Issuer or of any of its subsidiaries; (d) Any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) Any material change in the present capitalization or dividend policy of the Issuer; (f) Any other material change in the Issuer's business or corporate structure; (g) Changes in the Issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the issuer by any person; (h) Causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) A class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934; or (j) Any action similar to any of those enumerated above. Each of the Filing Parties reserve the right to propose or participate in future transactions which may result in one or more of the above listed actions, including but not limited to, an extraordinary corporate transaction, such as a merger, reorganization or liquidation, sale of a material amount of assets of the Issuer or its subsidiaries, or other transactions which might have the effect of causing the Common Stock to become eligible for termination of registration under Section 12(g) of the Act. The Filing Parties also retain the right to change their investment intent at any time, to acquire additional shares of Common Stock or other securities of the Issuer from time to time, or to sell or otherwise dispose of all or part of the Common Stock beneficially owned by them (or any shares of Common Stock into which such securities are converted) in any manner permitted by law. The Filing Parties may engage from time to time in ordinary course transactions with financial institutions with respect to the securities described herein.	2026-09-04
EMPD	Empery Digital Inc.	4	Item 4 is hereby amended to add the following: On August 28, 2026, the Court issued a memorandum opinion (the "Decision") in connection with the litigation initiated by the Complaint (the "Action"). The Decision addressed ATG Fund's claims that the Issuer's Board breached the Bylaws and breached its fiduciary duty in rejecting ATG Fund's Nomination Notice. In the Decision, the Court held that the Board "lacked contractual grounds to reject the Nomination Notice" and breached the Bylaws when it rejected ATG Fund's Nomination Notice. The Court also found that "the Board's reject[ion] [of] the Nomination Notice was inequitable and constituted a breach of the directors' fiduciary duties." The Decision expressly stated that "ATG [Fund]'s Nomination Notice is valid. ATG [Fund]'s nominees may stand for election at Empery's annual meeting." During the Action, the Defendants asserted that ATG Fund was required to disclose (a) a short position it held in certain Bitcoin ETFs (the "Bitcoin Short"), and (b) information concerning another stockholder, Tice Brown, as an alleged "participant" in ATG Fund's proxy campaign, in the Nomination Notice. The Defendants also asserted that ATG Fund was required to disclose the Bitcoin Short on its Schedule 13D filed on January 26, 2026, because ATG Fund stated that it might "engag[e] in short selling of or any hedging or similar transaction with respect to the Shares." The Court found that disclosure of the Bitcoin Short is not required under the Bylaws and that "ATG [Fund] could not fairly be expected to guess that the Board would interpret the Bylaws to require the disclosure of a Bitcoin short position." The Court held that the Defendants actions "reflect[] a misunderstanding of not only basic contract interpretation, but also the purpose advance notice bylaws serve under Delaware law." We believe that the Defendant's assertion that ATG Fund was required to disclose the Bitcoin Short on its Schedule 13D filing is also baseless, and that the January 26 Schedule 13D is accurate as the reference to "Shares," as defined therein, is to the Issuer's common stock and does not refer to hedging transactions in Bitcoin ETFs. As the Decision notes, ATG Fund previously held the Bitcoin Short. Given the Issuer's operational shift, ATG Fund has since closed out the Bitcoin Shorts and, as of the date hereof, no longer holds any short positions in Bitcoin ETFs. For the avoidance of doubt, other than its previously disclosed brief short sale of February 2026 call options, ATG Fund has never held short positions in any securities of the Issuer. In its post-trial brief, the Issuer asserted new allegations that Mr. Brown was a member of a "group" for the purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, and/or had agreements, arrangement or understandings with respect to the Issuer with ATG Fund. In the Decision, the Court found that "Mr. Brown is not a participant in ATG [Fund's] solicitation" and that ATG Fund was not required to include information concerning Mr. Brown in the Nomination Notice. The Court did not reach a decision regarding the Issuer's other claims regarding Mr. Brown raised in the post-trial brief. ATG Fund vigorously disputes these allegations. The foregoing description of the Decision does not purport to be complete and is qualified in its entirety by reference to the full text of the Decision, a copy of which is attached hereto as Exhibit 99.1 and incorporated herein by reference.	2026-09-03
RNW	ReNew Energy Global plc	4	This Amendment amends and supplements Item 4 of the Original Schedule 13D by adding the following: Transaction Agreement On August 11, 2026, the Issuer and a consortium comprising CPP Investments and the founder, Chairman and CEO of the Issuer, Mr. Sumant Sinha (together with CPP Investments, the "Consortium") entered into a Transaction Agreement (the "Transaction Agreement"). Under the terms of the Transaction Agreement, each Share of the Issuer that is not held by the Consortium and their respective affiliates, not held as a treasury share by the Issuer and not a Rollover Share (as defined below) will be transferred to CPP Investments, for cash consideration of US$7.02 per share, without interest and subject to applicable withholding taxes (the "Consideration"), to be implemented by means of a scheme of arrangement sanctioned by the High Court of Justice of England and Wales (the "Court") under Part 26 of the U.K. Companies Act 2006 (the "Scheme" and together with related transactions contemplated by the Transaction Agreement, the "Transaction"). Rather than receiving the Consideration in cash, each shareholder of the Issuer (other than any shareholder residing in India, who may not elect to participate in the Rollover as defined below) may elect to retain all of its shares of the Issuer, which will remain outstanding following the Scheme and in respect of which no Consideration or other distributions will be paid (a "Rollover", the shares so retained (and subject to the cutbacks described in the Transaction Agreement), the "Rollover Shares", and any Issuer shareholder holding any Rollover Shares, a "Rollover Shareholder"). Irrevocable Undertaking In connection with the Transaction, JERA Power RN B.V. ("JERA Power") has delivered an irrevocable undertaking in favor of the Consortium (the "Irrevocable Undertaking"). Pursuant to the Irrevocable Undertaking, JERA Power undertakes, among other things, to: (i) exercise (or procure the exercise of) all voting rights attaching to its Shares in favor of the Scheme, the Transaction and the related resolutions (and against any resolution to adjourn the relevant shareholder meetings, amend the Scheme, or which is likely to result in a condition of the Scheme not being fulfilled, impede or frustrate the Scheme, or prevent the Scheme from becoming effective); (ii) if the Transaction is implemented by way of a takeover offer, accept that offer in respect of its Shares; (iii) elect to participate in the Rollover in respect of all of its Shares; (iv) refrain from disposing of, or dealing in, its Shares, from acquiring further securities in the Issuer, from entering into third-party arrangements relating to its Shares and from taking any action that would restrict its ability to control the exercise of rights attaching to its Shares, in each case, other than pursuant to the Transaction; and (v) cooperate in the implementation of the Reorganization of the Issuer (as defined below) to be undertaken after the Effective Time of the Scheme (as defined below) and enter into the related Reorganization Deed (as defined below) and the Shareholders' Agreement (as defined below) to be entered into in connection with the Transaction, and provide reasonable cooperation in connection with obtaining required regulatory clearances (subject to customary confidentiality and privilege carve-outs). The Irrevocable Undertaking will lapse in specified circumstances, including if the Transaction Agreement is terminated, if the Scheme lapses or is withdrawn, if the Scheme is not effective (or the offer is not unconditional) by the specified long-stop time, or if a competing offer for the entire issued and to-be-issued share capital of the Issuer becomes effective or is declared unconditional. The foregoing description of the Irrevocable Undertaking does not purport to be complete and is qualified in its entirety by reference to the full text of the Irrevocable Undertaking, a copy of which is filed as Exhibit 99.8 to this Schedule 13D and is incorporated herein by reference. Pursuant to Section 13(d) of the Act, by virtue of the Irrevocable Undertaking described in this Schedule 13D, the Consortium may be deemed to be a member of a "group" with JERA Power. However, the Reporting Persons expressly disclaim beneficial ownership of the Shares beneficially owned by the Consortium, their affiliates or any other reporting person(s). Neither the filing of this Schedule 13D nor any of its contents shall be deemed to constitute an admission that the Reporting Persons beneficially own any Shares that are beneficially owned by the Consortium, their affiliates or any other reporting person(s). The Reporting Persons are only responsible for the information contained in this Schedule 13D and assume no responsibility for information contained in any other Schedule 13D filed by the Consortium, their affiliates or any other reporting person(s). Reorganization and Form of Reorganization Deed Concurrently with the execution of the Transaction Agreement, the Consortium has agreed with JERA Power the form of the Reorganization Deed and the form of the steps plan attached thereto (the "Reorganization Deed"). The Reorganization Deed, which will come into effect at the time at which an order of the Court sanctioning the Scheme is delivered to the Registrar of Companies (the "Effective Time", and the date on which the Effective Time occurs, the "Effective Date"), is the legal framework agreement that will bind the Consortium and Rollover Shareholders to the legal steps (the "Reorganization Steps") that will be undertaken after the Effective Time to effect a reorganization of the Issuer and its subsidiaries (the "Reorganization"), the result of which will be that all shareholders of the Issuer at the Effective Time will become direct shareholders of ReNew Private Limited, a wholly-owned subsidiary of the Issuer ("RPL"). The Reorganization Steps include the below steps, to occur in chronological order: 1. Constitutional Amendments. Once consummation of the Transaction has taken place, the share capital of the Issuer, which is currently comprised of four share classes, will be harmonized into a single class of ordinary shares with pari passu voting and economic rights. 2. The 'Re-Domicile'. Once the Issuer has been re-registered as a private company after consummation of the Transaction, it will transfer at fair market value (which, absent any significant delay between consummation of the Transaction and the re-domicile, is expected to be equivalent to the valuation considered for the purpose of the Transaction) its shares in RPL to each of the Issuer's shareholders on a pro rata basis (based on economic, rather than voting rights), which will have the effect of moving their shareholding to RPL directly. The consideration payable by each shareholder of the Issuer for the transfer of the relevant RPL shares to that shareholder will be left outstanding as a debt owed by that shareholder to the Issuer (the "Consideration Debt"). The Issuer will then immediately declare a distribution to each shareholder of an amount equal to that shareholder's Consideration Debt, and the amount owed by the Issuer to the shareholder under that distribution will be set off against the Consideration Debt so that the two amounts cancel out and no shareholder (nor the Issuer) is required to make a cash payment. The description of the Reorganization and the form of the Reorganization Deed contained in this Item 4 is not intended to be complete. A more detailed description of the Reorganization and the Reorganization Deed will be provided in the Scheme Circular, and a copy of the Reorganization Deed will be attached as an exhibit thereto. Form of the Shareholders' Agreement Concurrently with the execution of the Transaction Agreement, the Consortium has also agreed to a form of shareholders' agreement, which is expected to be entered into at the Effective Time (the "Shareholders' Agreement") by and among the Consortium and certain other continuing shareholders of the Issuer (and the applicable affiliates of the foregoing) that will hold the Rollover Shares (collectively, the "Investors"). The Shareholders' Agreement will govern the ownership and control of the Issuer from and after the Effective Time until the completion of the Reorganization, and RPL, the primary operating subsidiary of the Issuer, from and after the completion of the Reorganization, and will contain, among others, the following material terms (any reference to RPL below is also a reference to the Issuer for the period from and after the Effective Time until the completion of the Reorganization): Governance o Director Appointment Rights: The board of directors of the Issuer (the "Board") and, following completion of the Reorganization Steps, RPL will consist of the number of directors appointed in accordance with the following provisions: (i) the Investor who holds (A) an aggregate ownership interest in RPL or Issuer (as applicable) of more than 50% (on a non-diluted basis), or (B) an aggregate ownership interest of 40% or more and is the single largest ownership interest in RPL or Issuer (as applicable) (on a non-diluted basis) (in either case, the "Controlling Investor") will be entitled to appoint an unlimited number of directors to the Board; (ii) each Investor holding 10% or more of the ownership interest in RPL (on a non-diluted basis) (to the extent not already entitled to appoint an unlimited number of directors under the preceding clause) will be entitled to appoint one director to the Board; (iii) an Investor holding less than 10% of the ownership interest in RPL (on a non-diluted basis) will not hold any director appointment rights; (iv) Mr. Sinha will be entitled to serve as a director on the Board, subject to certain sunset provisions set forth in the Shareholders' Agreement; and (v) any Investor holding 5% or more of the ownership interest in RPL (on a non-diluted basis) will be entitled to appoint a non-voting observer to the Board. Reserved Matters o The Shareholders' Agreement contains customary "reserved matters" provisions, which require the approval of at least 87.6% of the ownership interests in RPL (on a non-diluted basis), in some cases, and at least 95% of the ownership interests in RPL (on a non-diluted basis), in other cases, prior to RPL taking certain specified actions set forth in the Shareholders' Agreement. Transfer Restrictions o The Shareholders' Agreement contains a three-year lock-up binding on all Investors (other than the Controlling Investor), as well as a right of first offer in favor of the Controlling Investor and tag/drag-along rights in respect of transfers by the Controlling Investor. Indian IPO o Within 12 months following the Effective Time, the Board will establish a "Strategic Options Committee" comprised of at least five members, to include (i) Mr. Sinha (for as long as he remains a director), (ii) one member appointed by each Investor holding 12.5% or more of the ownership interests in RPL (on a non-diluted basis) and (iii) a remaining number, sufficient to comprise a majority, appointed by the Controlling Investor, to oversee preparation for the admission of RPL's ordinary shares to a recognized stock exchange. The description of the form of the Shareholders' Agreement contained in this Item 4 is not intended to be complete. A more detailed description of the form of the Shareholders' Agreement will be provided in the Scheme Circular, and a copy of the form of the Shareholders' Agreement will be attached as an exhibit thereto. Other than as described in this Schedule 13D, the Reporting Persons have no plans or proposals of the type referred to in clauses (a) through (j) of Item 4 of Schedule 13D that relate to their investment in the Issuer, although they and their affiliates reserve the right to formulate such plans or proposals in the future. If the Transaction does not proceed, the Reporting Persons will continue to regularly review and assess their investment in the Issuer and depending on market conditions, general economic and industry conditions, the Issuer's business and financial condition and/or other relevant factors, the Reporting Persons may or may not: (i) purchase or sell the Shares or other securities of the Issuer in the future on the open market or in private transactions, or (ii) determine, from time to time, to engage in any of the events set forth in clauses (a) through (j) of Item 4 of Schedule 13D.	2026-08-11
EVGN	EVOGENE LTD.	4	Item 4 of the Schedule 13D is hereby amended to add the following at the end thereof: On August 28, 2026, the Reporting Persons disseminated a communication to shareholders entitled "Response of L.I.A. Pure Capital and Invest-Pro to Evogene's August 25, 2026 Press Release." In such communication, the Reporting Persons expressed their views regarding the Issuer's performance, governance and board composition and encouraged shareholders to support the Reporting Persons' nominees for election to the Issuer's board of directors at the Issuer's upcoming annual meeting of shareholders. A copy of such communication is attached hereto as Exhibit 8 and is incorporated herein by reference. .	2026-08-28
LBRDA	Liberty Broadband Corporation	4	The information contained in Item 4 of the Schedule 13D is hereby amended to delete last three paragraphs thereof and supplemented to include the following information: As previously disclosed by the Issuer, on November 12, 2024, the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement") with Charter Communications, Inc. ("Charter"), Fusion Merger Sub 1, LLC, a Delaware limited liability company and wholly owned subsidiary of Charter ("Merger LLC"), and Fusion Merger Sub 2, Inc., a Delaware corporation and wholly owned subsidiary of Merger LLC ("Merger Sub"), whereby, subject to the terms thereof, (i) Merger Sub would merge with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as the surviving corporation and a wholly owned subsidiary of Merger LLC, and (ii) the Merger would be immediately followed by a merger of, the Issuer, as such surviving corporation, with and into Merger LLC (the "Upstream Merger", and together with the Merger, the "Combination"), with Merger LLC surviving the Upstream Merger as the surviving company and a wholly owned subsidiary of Charter. On August 19, 2026, the transactions contemplated by Merger Agreement, including the Combination, were completed, and each share of Series B common stock and the Issuer's Series A common stock, par value $0.01 per share, and the Issuer's Series C common stock, par value $0.01 per share, was automatically converted into 0.2360 of a validly issued, fully paid and nonassessable share of Charter's Class A common stock, par value $0.001 per share, except that cash (without interest) was paid in lieu of fractional shares, and accordingly as a result of the completion of the Merger the Reporting Person disposed of all of the shares of Series B common stock beneficially owned by the Reporting Person and ceased to be the beneficial owner of any shares of Series B common stock.	2026-08-20
AMRX	Amneal Pharmaceuticals, Inc.	3	This Amendment No. 7 to Schedule 13D (this "Amendment No. 7") amends and supplements the Schedule 13D filed with the SEC on July 9, 2018 (the "Initial 13D" and, as amended and supplemented through the date of this Amendment No. 7, the "Schedule 13D"), by the Reporting Person relating to Class A Common Stock of the Issuer. Capitalized terms used but not defined in this Amendment No. 7 shall have the meanings set forth in the Schedule 13D.	2026-08-12
CHTR	CHARTER COMMUNICATIONS, INC. /MO/	3	The information with respect to the consummation of the Transactions and the Ancillary Agreements entered into in connection therewith, as well as the continued Suspension of the Share Repurchases set forth in Items 5(c) and 6 is incorporated herein by reference to the extent responsive to this Item 4.	2026-08-21
INVX	Innovex International, Inc.	3	Item 4 of the Schedule 13D is hereby amended and supplemented by the addition of the following: Underwriting Agreement On August 6, 2026, the Issuer entered into an Underwriting Agreement (the "Underwriting Agreement") with Intervale Capital Fund II, L.P., Intervale Capital Fund II-A, L.P., Intervale Capital Fund III, L.P., Amberjack Capital Fund II, L.P., Innovex Co-Invest Fund, L.P., Innovex Co-Invest Fund II, L.P., (collectively, the "Seller Stockholders") and Barclays Capital Inc., as underwriter (the "Underwriter"), relating to the offer and sale by the Selling Stockholders of 5,000,000 shares of common stock, par value $0.01 per share, of the Issuer (the "Common Stock"), at a price to the Underwriter of $28.71 per share (the "Offering"). Amberjack Capital Fund II, L.P. sold 3,706,801 shares of Common Stock to the Underwriter. Innovex Co-Invest Fund II, L.P. sold 865,508 shares of Common Stock to the Underwriter. Innovex Co-Invest Fund, L.P. sold 205,126 shares of Common Stock to the Underwriter. Intervale Capital Fund II, L.P. sold 176,944 shares of Common Stock to the Underwriter. Intervale Capital Fund II-A, L.P. sold 88 shares of Common Stock to the Underwriter. Intervale Capital Fund III, L.P. sold 45,533 shares of Common Stock to the Underwriter. The Offering closed on August 10, 2026. The Underwriting Agreement contains customary representations and warranties, agreements and obligations, closing conditions and termination provisions. The foregoing description of the Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Underwriting Agreement, which is incorporated by reference as Exhibit 99.1 and is incorporated herein by reference. Lock-up Agreement On August 6, 2026, the Underwriter entered into a lock-up agreement with the Selling Stockholders (the "Lockup Agreement"). Under the Lockup-Agreement, the Selling Stockholders agreed to not and not to cause any affiliates to, during the period beginning on the date of the Lock-up Agreement and ending at the close of business 45 days after the date of the final prospectus relating the Offering, to transfer any Common Stock or any shares underlying such Common Stock without the prior written consent of the Underwriter, subject to certain exceptions. The foregoing description of the Lock-Up Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Form of Lock-Up Agreement, which is incorporated by reference as Exhibit 99.2 and is incorporated herein by reference.	2026-08-13
GSHD	GOOSEHEAD INSURANCE INC -A	3	The Reporting Persons acquired, and presently hold, Class A Common Stock and Class B Common Stock for investment purposes. Each Reporting Person has signed and is a party to the Voting Agreements described in Item 2 above. Except as otherwise described herein and Rule 10b5-1 Trading Plans, none of the Reporting Persons currently has any plans or proposals that would result in or relate to any of the transactions or changes listed in Items 4(a) through 4(j) of Schedule 13D. However, as part of their ongoing evaluation of their investment and investment alternatives, the Reporting Persons may consider such matters and, subject to applicable law, may formulate a plan with respect to such matters or make formal proposals to the board of directors of the Issuer, other stockholders of the Issuer or other third parties regarding such matters. The Reporting Persons reserve the right to acquire additional securities of the Issuer in the open markets, in privately negotiated transactions (which may be with the Issuer or with third parties) or otherwise, to dispose of all or a portion of their holdings of securities of the Issuer or to change their intention with respect to any or all of the matters referred to in this Item 4.	2026-08-24
CISS	C3is Inc.	3	The Reporting Person involved in the securities described in this Schedule 13D in connection with the Spin-Off Distribution, and intends to review its investment in the Issuer on a continuing basis. The Reporting Person may from time to time acquire additional securities of the Issuer, or retain or sell all or portion of the shares then held by the Reporting Person, in the open market, block trades, underwritten public offerings or privately negotiated transactions. Any actions the Reporting Person might undertake with respect to its investment in the Issuer may be made at any time and from time to time and will be dependent upon the Reporting Person's review of numerous factors, including, but not limited to: ongoing evaluation of the Issuer's business, financial condition, operations, prospects and strategic alternatives; price levels of the Issuer's securities; general market, industry and economic conditions; the relative attractiveness of alternative business and investment opportunities; tax considerations; liquidity of the Issuer's securities; and other factors and future developments. Mr. Vafias serves as the Non-Executive Chairman of the Issuer and John Kostoyannis and George Xiradakis each serve as a director of the Issuer, other shareholders of the Issuer and other relevant parties, which discussions may include matters ranging from the operations and conduct of the Issuer's business to considering or exploring extraordinary corporate transactions including the events listed in Item 4(a) through 4(j) of Schedue 13D. In connection with these discussions, the Reporting Person may, either directly or through one or more affiliates, determine to take any available course of action or to take no course of action and may at any time and from time to time take steps to further or implement such course of action, including any of the events listed in Item 4(a) through 4(j) of Schedule 13D. Any action or actions the Reporting Person may undertake with respect to its investment in the Issuer or the operations and conduct of the Issuer's business will be dependent upon the Reporting Person's review of numerous factors, including those listed above, and the Reporting Person specifically reserves the right to change its intentions, or to formulate plans and proposals, with respect to any or all of the matters described in this paragraph, subject to applicable law and regulations.	2026-08-28
BNBX	BNB PLUS CORP.	3	Item 4 of the Schedule 13D is hereby amended to add the following: Strategic Review Update; Relationship to GlobalStake. The strategic review of the Issuer's businesses being conducted by an affiliate of the Reporting Persons has been substantially undertaken, and the Board has considered and, in certain cases, begun to implement recommendations arising from that review. Specifically, an existing asset management agreement has been terminated, resulting in significant net savings for the Issuer. In addition, the review suggested the addition to the Board of members with digital asset and related industry experience. Richard Shorten indirectly controls GlobalStake, the entity engaged by the Issuer to conduct the strategic review, and serves as the engagement leader for GlobalStake's engagement by the Issuer. The Reporting Persons expect that additional recommendations arising from the strategic review may be considered and, if approved by the Board, implemented in the future. Certain recommendations arising from the strategic review may involve transactions in which GlobalStake or its affiliates would be a principal party. Appointment of Richard Shorten to the Board. Richard Shorten, a Reporting Person, was appointed to serve as a member (and new Chairman) of the Board, effective September 3, 2026. Prior to such appointment, Richard Shorten was interviewed by the Issuer's nominating committee and by the Board. Following that process, the committee recommended, and the Board independently determined, to appoint Richard Shorten to the Board. Recommendation of Additional Director Candidates; Resulting Board Composition. In connection with the Board's consideration of candidates, the Reporting Persons recommended two individuals, Lok Lee and Todd Larsen, as potential director candidates. The Issuer's nominating committee and the Board interviewed each candidate, independently evaluated his qualifications, and thereafter independently determined to appoint each such individual to the Board, effective September 3, 2026. As of the date of this Amendment, the Board consists of five members, of whom three - Richard Shorten, Todd Larsen and Lok Lee - were appointed following the Reporting Persons' recommendation. The Reporting Persons do not have any agreement, arrangement, or understanding - written or oral, formal or informal - with any candidate appointed or nominated to the Board regarding such person's service on the Board, the exercise of such person's fiduciary duties, or the acquisition, holding, voting, or disposition of any securities of the Issuer. Conflicts Process. The Reporting Persons have advised the Issuer that Richard Shorten will recuse himself from Board deliberations and voting with respect to the engagement of GlobalStake and with respect to any transaction in which GlobalStake may have an interest or otherwise as may be required by applicable law. No Agreements Regarding Board Service or Securities. The Reporting Persons have no agreement, arrangement, or understanding with the Issuer with respect to the appointment of Richard Shorten or of any other individual to the Board, and have no right to designate any director of the Issuer. The Reporting Persons have no agreement, arrangement, or understanding of any kind with the individuals recommended as director candidates, with respect to (i) the acquisition, holding, voting, or disposition of any securities of the Issuer, (ii) such individuals' service on, or conduct as members of, the Board, or (iii) the exercise of such individuals' fiduciary duties. Neither of such individuals is employed by, or receives any compensation, indemnification, or reimbursement from, the Reporting Persons or any of their affiliates with respect to service on the Board and, to the knowledge of the Reporting Persons, neither such individual owns any securities of the Issuer. Disclaimer of Group Status. The Reporting Persons expressly disclaim membership in any 'group' within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, or Rule 13d-5(b) thereunder, with (i) the Issuer, (ii) any other stockholder of the Issuer, or (iii) any member of the Board, including any director recommended by the Reporting Persons. Each member of the Board exercises independent judgment and owes fiduciary duties to the Issuer and all of its stockholders. Continuing Reservation of Rights. The Reporting Persons intend to continue to engage with the Issuer's Board and management regarding the strategic direction of the Issuer, the implementation of recommendations arising from the strategic review, and other matters affecting shareholder value. The Reporting Persons intend to review their investment in the Issuer on a continuing basis and may, at any time and from time to time, engage in discussions with members of the Board, management of the Issuer, other stockholders, potential investors, strategic partners and other interested parties regarding the Issuer's business, operations, management, governance, strategy, capitalization, capital allocation, financial condition and prospects. Depending upon various factors, including the Issuer's business and financial position and prospects, the price level of the Common Stock, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may, at any time and from time to time, review or reconsider their position, change their purpose, formulate plans or proposals with respect thereto, or take any other action with respect to their investment in the Issuer as they deem appropriate, including acquiring additional securities, disposing of securities, proposing or considering changes in the Issuer's operations, management, Board composition, governance, capitalization or strategic direction, or considering or proposing one or more of the actions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.	2026-09-04
VNOM	Viper Energy, Inc.	3	Item 4 of the Schedule 13D is hereby amended and supplemented as follows: Closing of the Purchase Agreement On September 1, 2026, the previously disclosed Purchase Agreement closed. As a result, the Reporting Persons acquired an aggregate of 3,815,459 OpCo units and an equivalent number of shares of the Issuer's Class B Common Stock.	2026-09-03
MBX	MBX BIOSCIENCES, INC.	3	The Reporting Persons from time to time intend to review their investment in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the Issuer's Shares in particular, as well as other developments and other investment opportunities. Based upon such review, the Reporting Persons will take such actions in the future as the Reporting Persons may deem appropriate in light of the circumstances existing from time to time. If the Reporting Persons believe that further investment in the Issuer is attractive, whether because of the market price of Shares or otherwise, they may acquire Shares or other securities of the Issuer either in the open market or in privately negotiated transactions. Similarly, depending on market and other factors, the Reporting Persons may determine to dispose of some or all of the Shares currently owned by the Reporting Persons or otherwise acquired by the Reporting Persons either in the open market or in privately negotiated transactions. Except as set forth in this Schedule 13D, the Reporting Persons have not formulated any plans or proposals which relate to or would result in: (a) the acquisition by any person of additional securities of the Issuer or the disposition of securities of the Issuer, (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries, (c) a sale or transfer of a material amount of the assets of the Issuer or any of its subsidiaries, (d) any change in the present Board of Directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board, (e) any material change in the Issuer's capitalization or dividend policy of the Issuer, (f) any other material change in the Issuer's business or corporate structure, (g) any change in the Issuer's charter or bylaws or other instrument corresponding thereto or other action which may impede the acquisition of control of the Issuer by any person, (h) causing a class of the Issuer's securities to be deregistered or delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association, (i) a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act or (j) any action similar to any of those enumerated above.	2026-08-14
WLDS	Wearable Devices Ltd.	3	Item 4 of the Schedule 13D is hereby amended to add the following at the end thereof: On August 7, 2026, the Reporting Persons entered into a Cooperation Agreement (the "Cooperation Agreement") with the Issuer to resolve the matters raised in the Reporting Persons' demand letter requesting that the Issuer convene a special general meeting of shareholders (the "Demand Letter") and the legal proceedings commenced by the Reporting Persons in connection with the Issuer's previously announced private placement (the "Court Proceedings"). Pursuant to the Cooperation Agreement, effective three business days following the dismissal of the legal proceedings, two existing directors of the Issuer will resign from the Issuer's board of directors and the Issuer will take the necessary actions to appoint four new directors to the Issuer's board of directors. Following such appointments and resignations, the Issuer's board of directors will consist of seven members. In addition, pursuant to the Cooperation Agreement, the Reporting Persons agreed to irrevocably withdraw their Demand Letter and cease all efforts in furtherance thereof, and the parties agreed that the Court Proceedings would be dismissed with no order as to costs. On August 10, 2026, following the filing of a joint notice and motion for termination of the Court Proceedings, the Court dismissed the Court Proceedings with no order as to costs. Moreover, pursuant to the Cooperation Agreement, each Reporting Person agreed, for a period of two years following the execution of the Cooperation Agreement, to cause its affiliates to refrain from taking any direct or indirect action to knowingly hinder, interfere with, change or influence the Issuer's or any of its subsidiaries' corporate governance, operations, management or board composition, except as expressly permitted by the Cooperation Agreement, with the prior written consent of the Issuer or in connection with voting its shares at meetings of the Issuer's shareholders. The Cooperation Agreement also contains certain mutual release and non-disparagement provisions applicable to the parties. The releases do not include rights or claims to enforce the Cooperation Agreement or claims relating to fraud, malicious actions or willful misconduct. In connection with the Cooperation Agreement, on August 7, 2026, J.B.D Innovation Ltd. entered into a Side Letter with the Issuer pursuant to which it committed, for a period of 24 months, to provide financing to the Issuer if the Issuer's board of directors determines in good faith that the Issuer does not have sufficient financial resources to fund its operations for the following 24 months. If such condition is satisfied, J.B.D Innovation Ltd. has agreed to provide debt financing in an aggregate principal amount of not less than $12.0 million for the purpose of funding the Issuer's ongoing current business operations. Such financing would be structured as convertible debt and would be subject to negotiation and execution of definitive financing documentation. The foregoing description of the Cooperation Agreement and the Side Letter is qualified in its entirety by reference to the full text thereof, copies of which are filed as exhibits hereto and incorporated herein by reference.	2026-08-14
ETOR	eToro Group Ltd.	3	The information set forth in Item 4 of the Original 13D is incorporated herein by reference.	2026-09-04
TALK	Talkspace, Inc.	3	Item 4 of the Existing Schedule 13D is hereby amended and supplemented by adding the following: On August 17, 2026, the merger (the "Merger") contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated March 9, 2026, by and among the Issuer, Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub") was consummated. Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer, and the Issuer continued as the surviving corporation as an indirect wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each outstanding share of Common Stock (other than shares of Company Common Stock to be canceled pursuant to the Merger Agreement and shares with respect to which appraisal rights were properly exercised and not withdrawn under Delaware law) was automatically converted into the right to receive $5.25 in cash, without interest (the "Merger Consideration"). In addition, as of the Effective Time, each stock option granted under the Issuer's equity incentive plans (a "Stock Option") that was vested as of the Effective Time (each, a "Vested Stock Option") was cancelled and converted into the right to receive an amount in cash equal to the excess, if any, of (i) the Merger Consideration over (ii) the per share exercise price of such Vested Stock Option. Each restricted stock unit granted under the Issuer's equity incentive plans ("RSU") that was vested, but not yet settled, as of the Effective Time, was cancelled and converted into the right to receive the Merger Consideration for each RSU. Immediately prior to the Effective Time, each of the Issuer's directors, including Mr. Shachar, resigned from, and ceased serving on, the Issuer's board of directors. Following the Merger, the Reporting Persons no longer beneficially own any securities of the Issuer, nor do they have sole or shared power to vote, direct the vote, dispose or direct the disposition of, any securities of the Issuer. The Common Stock will no longer be listed on Nasdaq and will be deregistered under Section 12(b) of the Exchange Act.	2026-08-17
UEIC	UNIVERSAL ELECTRONICS INC	3	Item 4 is hereby amended to add the following: The sales reported herein were undertaken for the purpose of offsetting certain tax liabilities of the Reporting Persons.	2026-09-04
ESTC	Elastic N.V.	3	The Reporting Person acquired shares of Elastic NV as part of its investment strategy, which includes considering the clarity and robustness of the issuer's long-term strategy; the functioning and calibre of governance structures and effective leadership; the financial strength and performance of issuers and the fair valuation of underlying securities; and financially-material sustainability risks & opportunities. The Reporting Person is therefore actively engaging with the Issuer to discuss and promote initiatives that align with these business practices. This engagement is part of the Reporting Person's broader strategy to support companies in enhancing their approach, thereby potentially improving long-term shareholder value. As such, the Reporting Person may seek to influence the Issuer's policies and practices through discussions with the Boards and management of the companies in which we invest. The Reporting Person does not currently have any plans or proposals that would result in a change in control of the Issuer, nor does it intend to acquire additional shares for the purpose of gaining control. However, the Reporting Person reserves the right to change its intentions and take any actions that it deems appropriate in light of its ongoing engagement and evaluation of the Issuer's policies and practices.	2026-09-02
GAP	The Gap, Inc.	3	This Statement is filed on behalf of the Reporting Person to update the beneficial ownership information from that reported in the Schedule 13D. The Reporting Person reviews their investments in the Issuer on a continuing basis and may, at any time, consistent with the obligations of the Reporting Person under the federal securities laws, determine to increase or decrease their respective ownership of shares of the Issuer's Common Stock through purchases or sales of such Common Stock of the Issuer in the open market, in privately negotiated transactions or by gift or other transfers as circumstances dictate. From time to time, the Reporting Person has transferred shares to various entities controlled by him, disposed of certain shares to third parties by gift and sold shares of Issuer Common Stock in the open market and in privately negotiated transactions, and the Reporting Person may do so in the future. The review of his investment in the Issuer by the Reporting Person will depend on various factors, including the Issuer's business prospects, other developments concerning the Issuer, alternative investment opportunities, general economic conditions, money and stock market conditions, and any other facts and circumstances which may become known to the Reporting Person regarding his investment in the Issuer. At the time of filing this Statement, the Reporting Person has no plans to sell or to purchase additional shares of Common Stock of the Issuer in the open market or in privately negotiated transactions but may engage in such transactions in the future. At the time of the filing of this Statement, except as disclosed herein, the Reporting Person has no present plans or proposals in his capacity as a stockholder which relate to or would result in (i) the acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer, (ii) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries, (iii) a sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries, (iv) any change in the Board of Directors or management of the Issuer or any of its subsidiaries, (v) any material change in the present capitalization or dividend policy of the Issuer, (vi) any other material change in the Issuer's business or corporate structure; (vii) changes in the Issuer's charter or bylaws or other actions which may impede the acquisition of control of the Issuer by any person, (viii) causing a class of securities of the Issuer to be delisted from a national securities exchange or cease to be quoted in an inter-dealer quotation system of a registered national securities association, (ix) a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act or (x) any action similar to any of those described above. However, because the Reporting Person is a member of the Board of Directors of the Issuer, he may, from time to time, be involved in discussions which relate to one or more of the matters described in this Item 4. The Reporting Person disclaims any obligation to report on any plans or proposals with respect to the matters described in this Item 4 that develop or occur as a result of his role as a director of the Issuer and participation in decisions regarding the Issuer's actions.	2026-09-04
QSR	Restaurant Brands International Inc.	3	Item 4 of Schedule 13D is hereby amended to add the following language: As noted above, 3G RBH delivered to RBI LP an exchange notice to exchange 2,784,549 Exchangeable Units held by 3G RBH. The exchange notice became irrevocable on August 10, 2026 with respect to 2,784,549 Exchangeable Units. As announced by the Issuer on August 10, 2026, upon receipt of the exchange notice, the Issuer, in its capacity as general partner of RBI LP, elected to have RBI LP satisfy the 2026 Exchange by repurchasing 2,784,549 Exchangeable Units for cash. The 2026 Exchange will be effected as of the close of business on August 31, 2026. The Reporting Persons continue to hold 94,373,170 Exchangeable Units, for which they have not submitted any exchange notice. Except as set forth in this Schedule 13D and in connection with the Transactions and the other transactions discussed herein, the Reporting Persons have no plan or proposals that relates to or would result in any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.	2026-08-14

代码	申报人	类型	申报日期	持股数	持股比例
HZO	American Century Investment Management, Inc.	13G/A	2026-09-04	943K	4.3%
ALPS ETF Trust	TRUIST FINANCIAL CORP	13G/A	2026-09-04	63K	5.6%
ALPS ETF Trust	TRUIST FINANCIAL CORP	13G/A	2026-09-04	60K	8.8%
Themes ETF Trust	TRUIST FINANCIAL CORP	13G/A	2026-09-04	0	0.0%
JMM	SIT INVESTMENT ASSOCIATES INC	13G/A	2026-09-04	5.93M	62.6%
CABO	DAVENPORT & Co LLC	13G/A	2026-09-04	214K	3.8%
CNXU	Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund	13G/A	2026-09-04	4.31M	10.0%
AMG BBH Asset-Backed Credit Fund, LLC	BROWN BROTHERS HARRIMAN & CO	13D/A	2026-09-04	2.67M	63.4%
IPEX	KARPUS MANAGEMENT, INC.	13G/A	2026-09-04	0	0.0%
PGAC	KARPUS MANAGEMENT, INC.	13G/A	2026-09-04	820K	16.0%
RFAI	KARPUS MANAGEMENT, INC.	13G/A	2026-09-04	989K	24.8%
SSAC	KARPUS MANAGEMENT, INC.	13G/A	2026-09-04	1.20M	5.0%
YHNA	KARPUS MANAGEMENT, INC.	13G/A	2026-09-04	97K	2.3%
BACC	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	0	0.0%
CUB	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	0	0.0%
MOUNTAIN LAKE ACQUISITION CORP.	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	0	0.0%
ODYSSEUS (CAYMAN) LTD	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	0	0.0%
Presidio MidCo Inc.	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	0	0.0%
CHURCHILL CAPITAL CORP IX	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	0	0.0%
ALFUU	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	0	0.0%
SIMAU	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	0	0.0%
TMS	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	855K	1.6%
ADXN	Timothy Mark Dyer	13D/A	2026-09-04	19.17M	9.0%
GAP	Robert J. Fisher	13D/A	2026-09-04	45.62M	13.0%
GAP	John J. Fisher	13D/A	2026-09-04	45.80M	13.0%
RUM	Tether Global Investments Fund, S.I.C.A.F., S.A.	13D/A	2026-09-04	261.49M	50.3%
Presidio MidCo Inc.	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	0	0.0%
GRNT	GREP GP III, LLC	13D/A	2026-09-04	51.65M	39.2%
TREX	AllianceBernstein L.P.	13G/A	2026-09-04	202K	0.2%
UEIC	Ameriprise Financial, Inc.	13G/A	2026-09-04	1.70M	13.2%
CATX	Lantheus Holdings, Inc.	13D/A	2026-09-04	11.44M	10.0%
ETOR	Spark Capital II, L.P.	13D/A	2026-09-04	2K	0.0%
GPRK	Colden Investments S.A.	13D/A	2026-09-04	18.12M	27.9%
PAX	Capital Research Global Investors	13G/A	2026-09-04	0	0.0%
First Trust Exchange-Traded Fund V	First Trust Portfolios L.P.	13G/A	2026-09-04	1.45M	26.9%
First Trust Exchange-Traded Fund VI	First Trust Portfolios L.P.	13G/A	2026-09-04	19.58M	76.6%
First Trust Exchange-Traded Fund VI	First Trust Portfolios L.P.	13G/A	2026-09-04	994	0.0%
First Trust Exchange-Traded Fund VIII	First Trust Portfolios L.P.	13G/A	2026-09-04	2.15M	23.3%
First Trust Exchange-Traded Fund VIII	First Trust Portfolios L.P.	13G/A	2026-09-04	2.14M	34.3%
VanEck Emerging Markets High Yield Bond ETF	First Trust Portfolios L.P.	13G/A	2026-09-04	2.78M	10.7%
First Trust Exchange-Traded Fund VIII	First Trust Portfolios L.P.	13G/A	2026-09-04	58K	12.9%
MLR	Neuberger Berman Group LLC	13G/A	2026-09-04	1.14M	10.0%
AMSF	Neuberger Berman Group LLC	13G/A	2026-09-04	569	0.0%
BC Partners Lending Corp	First Trust Alternative Opportunities Fund	13G/A	2026-09-04	567K	14.6%
TCW SPECIALTY LENDING LLC	First Trust Alternative Opportunities Fund	13G/A	2026-09-04	2.30M	11.2%
BTCK	PenderFund Capital Management Ltd.	13G/A	2026-09-04	350K	2.9%
VBIO	3i, LP	13G/A	2026-09-04	133K	9.9%
BNBX	Comstock MultiChain Fund, L.P.	13D/A	2026-09-04	688K	9.9%
NPCE	First Light Asset Management, LLC	13G/A	2026-09-04	4.20M	12.3%
NVT	BlackRock, Inc.	13G/A	2026-09-04	17.17M	10.6%
LEU	BlackRock, Inc.	13G/A	2026-09-04	2.24M	11.6%
iShares GNMA Bond ETF	BlackRock, Inc.	13G/A	2026-09-04	1.03M	10.3%
LAZ	BlackRock, Inc.	13G/A	2026-09-04	10.87M	11.2%
LTH	BlackRock, Inc.	13G/A	2026-09-04	22.42M	10.0%
TENB	BlackRock, Inc.	13G/A	2026-09-04	19.33M	17.5%
THC	BlackRock, Inc.	13G/A	2026-09-04	8.08M	10.0%
WDAY	BlackRock, Inc.	13G/A	2026-09-04	19.67M	10.0%
BILL	BlackRock, Inc.	13G/A	2026-09-04	8.63M	10.1%
SMTC	BlackRock, Inc.	13G/A	2026-09-04	9.35M	10.0%
STRL	BlackRock, Inc.	13G/A	2026-09-04	3.09M	10.1%

常见问题

什么是 Schedule 13D 和 Schedule 13G？

两者都是投资人取得上市公司5%以上表决权股份时必须向 SEC 申报的披露文件。Schedule 13D 适用于具有主动或控制意图的投资人（通常是激进投资人），必须详细披露其意图；Schedule 13G 则是给被动型机构投资人（指数基金、共同基金）的简化申报，代表无意介入公司经营权。

为什么 13D 比 13G 更容易成为股价的重大信号？

13D 申报通常代表激进投资人有所行动——争取董事席位、推动公司出售、或要求战略转向。文件中的 Item 4（交易目的）会明确写出其意图，足以牵动股价。13G 申报人通常是被动投资，较不会单独引发市场反应。

13D/A 或 13G/A 这类修正申报代表什么？

修正申报是对先前 13D 或 13G 的更新——例如持股比例变动、新增意图声明、或某位联合申报成员退出申报团体。我们会保留每一次修正作为独立记录，并标记每个申报团体最新的一笔作为目前持股状态。

为什么有些申报看不到持股数？

2024年12月18日 SEC 结构化 XML 规定生效前的申报，有些只包含表头层级的身份资料，没有机器可读的持股数字。我们仍会显示这些申报，但持股数与比例栏位会留空，而不会用猜测的数字填补。

这份数据的实时性如何？

每日从 SEC EDGAR 抓取新申报。由于申报内容一旦提交就不会改变，加上规定必须在跨过5%门槛后10天内申报，本追踪器通常能在公开披露后一到两天内反映持股变化。

13D/13G 数据该如何搭配 13F 机构申报一起解读？

13F 显示的是机构每季汇总的持仓；13D/13G 则是特定投资人跨过5%门槛的近实时披露，13D 申报人还会附上明确意图。两者搭配使用，有助于区分「指数基金的例行再平衡」与「单一投资人的刻意集中下注」。

最活跃个股 (30天)

代码	公司名称	申报数	最新激进意图声明	最后申报
VBIO	Valion Bio, Inc.	8	This Item 4 is not being amended by this Amendment No. 7.	2026-09-04
ENHA	Enhanced Group Inc. (f/k/a A Paradise Acquisition Corp.)	8	Purchase Agreement. On June 14, 2026, the Issuer entered into the Purchase Agreement pursuant to which the Issuer agreed to issue and sell to the Reporting Person: (A) 1,285,347 shares of Class A Common Stock and (B) accompanying warrants to purchase 1,285,347 shares of Class A Common Stock (the "Warrants"). The Class A Common Stock and accompanying Warrants were issued separately. The combined purchase price per share of Class A Common Stock and accompanying Warrant was $3.89. The Private Placement closed on August 14, 2026, after the effectiveness of the Stockholder Consent (as defined in the Purchase Agreement). Registration Rights Agreement. On June 14, 2026, the Issuer also entered into a registration rights agreement with the Reporting Person (the "Registration Rights Agreement"), pursuant to which the Issuer has agreed to file a registration statement under the Securities Act with the SEC, covering the resale of the Class A Common Stock and the shares of Class A Common Stock underlying the Warrants no later than 30 days following the applicable closing date and to use commercially reasonable efforts to have the registration statement declared effective by the SEC at the earliest possible date but no later than the earlier of the 90th calendar day following the initial filing date of the registration statement, if the SEC notifies the Company that it will "review" the registration statement, and the fifth business day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that the registration statement will not be "reviewed" or will not be subject to further review. The foregoing description of the Purchase Agreement, the Warrants and the Registration Rights Agreement do not purport to be complete and are each qualified in their entirety by the full text of the form of such agreements, which are attached as exhibits to this Schedule 13D and incorporated herein by reference	2026-08-20
BETR	Better Home & Finance Holding Company	6	This Amendment No. 7 hereby amends and supplements Item 4 of the Schedule 13D by adding the following thereto: "On August 17, 2026, Vishal Garg and affiliated entities (the "Garg Group") filed with the SEC a preliminary consent statement on Schedule 14A, as amended by Amendment No. 1 thereto filed August 18, 2026 and Amendment No. 2 thereto filed August 25, 2026. Such consent statement states that the Garg Group is soliciting consents of the Issuer's stockholders for, among other things, the proposed removal without cause of the incumbent Issuer directors named therein. Such consent statement also states, among other things, that the previous written stockholder consents delivered to the Issuer on August 17, 2026 in connection with the proposed removal of such directors did not constitute a majority of the Issuer's voting power; and that the only consents that will be solicited by the Garg Group for the proposals described in such consent statement will be by way of such consent statement. The Reporting Persons are not affiliated with, and no Reporting Person is a participant in the consent solicitation being conducted by, the Garg Group. The Reporting Persons currently intend, at the appropriate time pursuant to such consent solicitation, to provide their consent to the removal of the directors named therein. The Reporting Persons acquired the Issuer securities reported herein for investment purposes. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending upon various factors, including, without limitation, the Issuer's financial position and strategic direction, developments concerning the Issuer's corporate governance arrangements, overall market, economic, and industry conditions, the trading price of the Issuer's securities, other investment opportunities available to the Reporting Persons, and the liquidity requirements of the Reporting Persons, the Reporting Persons may seek to increase or decrease their holdings of or their economic exposure to the securities of the Issuer. The Reporting Persons may communicate with other stockholders of the Issuer, directors or officers of the Issuer, and/or other persons regarding the Issuer's business, strategy, operations, management, corporate governance, financial position, and other matters concerning the Issuer. Except to the extent the foregoing may be deemed a plan or proposal, none of the Reporting Persons has any plans or proposals which relate to, or could result in, any of the matters referred to in subparagraphs (a) - (j) of Item 4 of Schedule 13D. The Reporting Persons may, at any time and from time to time, review or reconsider their position and/or change their purpose and/or formulate plans or proposals with respect thereto, and/or consider or propose one or more of the actions described in subparagraphs (a) - (j) of Item 4 of Schedule 13D."	2026-08-25
GNK	GENCO SHIPPING & TRADING LTD	5	Item 4 of the Current Schedule 13D is hereby amended and supplemented to add the following: On August 14, 2026, Diana issued a press release announcing that Diana has withdrawn its proposal submitted to the board of directors of the Issuer on June 17, 2026 to acquire all of the issued and outstanding Shares of the Issuer not already owned by Diana for $24.80 in cash (adjusted for the Issuer's recently declared dividend of $0.80 per Share) plus one share of stock of Diana valued at $2.54 based on Diana's 30-day volume-weighted average price as of June 16, 2026 (the "Offer"). Notwithstanding the withdrawal of the Offer, Diana intends to regularly review its investment in the Issuer and consider all potential courses of action in connection with the Issuer and its Shares. Based on such review, as well as other factors, Diana may from time to time and at any time: (i) acquire additional Shares of the Issuer in the open market, in privately negotiated transactions or otherwise; (ii) dispose of any or all of their Shares in the open market, in privately negotiated transactions or otherwise; and (iii) engage in any hedging or similar transactions with respect to the Shares. Any such actions that Diana might undertake may be made at any time without prior notice based on, among other things, Diana's review of numerous factors, including, but not limited to: an ongoing evaluation of the Issuer's business, financial condition, operations and prospects; price levels of the Issuer's Shares; general market, industry and economic conditions; the relative attractiveness of alternative business and investment opportunities available to Diana; and other future developments. Further, Diana may, and reserves the right to, formulate plans or make proposals that could relate to or result in any of the matters listed in Items 4(a) - (j) of Schedule 13D, modify or withdraw any such plan or proposal, or change its intentions with respect to previous plans or proposals, in each case at any time.	2026-08-27
SLMT	Brera Holdings PLC	4	Item 4 is hereby amended and restated to read as follows: The information set forth or incorporated in Item 3 is hereby incorporated by reference. On the Event Date, Mr. Sade, Ms. Maimon, Ms. Almheiri and Mr. Alnuaimi were appointed to the Board of Directors of the Issuer (the "New Directors"). As directors of the Issuer, each of the New Directors may be able to control the Issuer's business and influence the corporate activities of the Issuer, and expects in the future to discuss and make decisions in the ordinary course of his or her duties regarding plans or proposals with respect to the transactions described in clauses (a) through (j) of Item 4 of Schedule 13D. Depending on the factors discussed herein, each of the New Directors may, from time to time, in their individual capacities, acquire additional Ordinary Shares and/or retain and/or sell all or a portion of the Ordinary Shares held by such person in the open market or in privately negotiated transactions, and/or may distribute Ordinary Shares to be acquired or held by such person to other entities. Any actions that each of the New Directors might undertake will be dependent upon such person's review of numerous factors, including, among other things, the price levels of the Ordinary Shares, general market and economic conditions, ongoing evaluation of the Issuer's business, financial condition, operations and prospects, the relative attractiveness of alternative business and investment opportunities, such person's need for liquidity, and other future developments. Any future acquisitions of Ordinary Shares by each of the New Directors will be subject to the Issuer's policies, including its insider trading policy, as applicable. On the Event Date in connection with the PIPE and the related transactions, the Reporting Persons mutually agreed to dissolve and terminate their informal understanding to act as a "group" for purposes of Regulation 13D solely with respect to the Ordinary Shares of the Issuer. In connection with such determination, each of the Reporting Persons acknowledged and agreed that they are no longer members of a "group" within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Accordingly, effective as of the Event Date, the Reporting Persons no longer may be deemed a "group" within the meaning of Section 13(d)(3) of the Exchange Act and each of Mr. Hirsch, Mr. Sade, Mr. Haklili, Ms. Maimon, Ms. Almheiri and Mr. Alnuaimi separately beneficially owns less than 5% of the outstanding Ordinary Shares of the Issuer and shall cease to be Reporting Persons immediately after the filing of this Amendment. As a result of the Reporting Persons' termination of their informal understanding to act as a "group", except as set forth herein with respect to the New Directors and the Strategic Advisors, none of the Reporting Persons presently has any additional plans or proposals that relate to or that would result in any of the transactions or other matters specified in clauses (a) through (j) of Item 4 of Schedule 13D, but depending on the factors discussed herein, the Reporting Persons may change their purpose or formulate different plans or proposals with respect their investment in the Issuer at any time.	2026-08-21
GRNT	Granite Ridge Resources, Inc.	4	Item 4 of the Schedule 13D is hereby amended and supplemented as provided below. Distribution On August 19, 2026, the Fund III Filing Parties effected a pro rata distribution of an aggregate of 14,000,000 shares of Common Stock to their respective limited partners and members, consisting of 4,247,600 shares distributed by Holdco III-A and 9,752,400 shares distributed by Holdco III-B. Voting Agreement On August 25, 2023, GREP GP III (who had voting and dispositive power over Common Stock owned by Fund III and certain of its affiliates), GREP GP II (who had voting and dispositive power over Common Stock owned by Fund II and certain of its affiliates), and Matthew Miller, Griffin Perry, Thaddeus Darden and Kirk Lazarine (collectively, the "Voting Agreement Parties") entered into a Stockholder Voting Agreement (the "Voting Agreement"). Pursuant to the Voting Agreement, the Voting Agreement Parties irrevocably and unconditionally agreed to vote the 75,957,927 shares of Common Stock which the Voting Agreement Parties then held (and any other shares of Common Stock obtained by Voting Agreement Parties in the future) at any annual or special meeting of the Company's stockholders or in connection with any written consent of the Company's stockholders. During the period it was in effect, the Voting Agreement continued indefinitely, but could be terminated on 30 days prior written notice by Voting Agreement Parties holding a majority of the shares of Common Stock subject to the Voting Agreement. In connection with their entry into the Voting Agreement, the Voting Agreement Parties provided GREP GP III an irrevocable voting proxy to vote the shares subject to the Voting Agreement. Additionally, during the term of such agreement, the Voting Agreement Parties agreed not to transfer the shares covered by the Voting Agreement without the consent of GREP GP III, except pursuant to certain limited exceptions. The description of the Voting Agreement contained in this Item 4 is not intended to be complete and is qualified in its entirety by reference to such agreement, which is filed as an exhibit hereto and incorporated by reference herein. Termination of Voting Agreement Effective August 19, 2026, the Voting Agreement Parties terminated the Stockholder Voting Agreement dated August 25, 2023, and it is no longer in effect. As a result, the irrevocable proxy in favor of GREP GP III and the transfer restrictions thereunder have terminated. Open Market Acquisitions and Vesting of Restricted Stock On September 18, 2023, the following Filing Parties made open market acquisitions of shares of Common Stock: Matthew Miller acquired 17,284 shares at prices ranging from $5.73 to $5.85 per share; Griffin Perry acquired 2,000 shares at a price of $5.76 per share, Thaddeus Darden acquired 20,000 shares at a price of $5.74 per share, and Kirk Lazarine acquired 10,000 shares at a price of $5.75 per share. On November 30, 2023, Thaddeus Darden acquired 10,000 shares at a price of $5.92 per share. On December 4, 2023, the following Filing Parties made open market acquisitions of shares of Common Stock: Griffin Perry acquired 3,000 shares at a price of $5.89 per share, and Thaddeus Darden acquired 10,000 shares at a price of $5.80 per share. On December 12, 2023, Matthew Miller acquired 2,600 shares at a price of $5.93 per share. On January 3, 2024, pursuant to an award of restricted stock granted to each of the Company's director under the Company's 2022 Omnibus Incentive Plan, 8,813 shares of restricted Common Stock issued to each of Matthew Miller, Griffin Perry, Thaddeus Darden, and Kirk Lazarine vested. On March 14, 2025 and March 15, 2024, Matthew Miller acquired a total of 4,900 shares at prices ranging from $6.20 to $6.22 per share. On May 23, 2024, Griffin Perry acquired 2,000 shares at a price of $6.54 per share. On June 3, 2024 through June 17, 2024, Matthew Miller acquired a total of 16,683 shares at prices ranging from $5.90 to $6.50 per share. On June 6, 2024, Thaddeus Darden acquired 3,000 shares at a price of $6.29. On June 14, 2024, Thaddeus Darden acquired 7,000 shares at a price of $5.90 per share. On August 16, 2024, Matthew Miller acquired 4,938 shares at a price of $6.50 per share. On August 22, 2024, Matthew Miller acquired 4,000 shares at a price of $6,33 per share. On September 11, 2024, Matthew Miller acquired 8,500 shares at a price of $5.97 per share. On September 13, 2024, Matthew Miller acquired 495 shares at a price of $6.23 per share. On September 12, 2024, Griffin Perry acquired 5,000 shares at a price of $6.13 per share. On November 20, 2024, Matthew Miller acquired 18,173 shares at prices ranging from $6.47 to $6.53 per share. On November 21, 2024, Matthew Miller acquired 20,327 shares at prices ranging from $6.59 to $6.63 per share. On December 6, 2024, the following Filing Parties made open market acquisitions of shares of Common Stock: Thaddeus Darden acquired 9,440 shares at prices ranging from $6.10 to $6.13 per share. Matthew Miller acquired 31,000 shares at prices ranging from $6.05 to $6.12 per share. Except as set forth in this Schedule 13D, the Filing Parties do not have any plan or proposal that would relate to, or result in, any of the following matters: (a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the Issuer or of any of its subsidiaries; (d) Any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) Any material change in the present capitalization or dividend policy of the Issuer; (f) Any other material change in the Issuer's business or corporate structure; (g) Changes in the Issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the issuer by any person; (h) Causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) A class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934; or (j) Any action similar to any of those enumerated above. Each of the Filing Parties reserve the right to propose or participate in future transactions which may result in one or more of the above listed actions, including but not limited to, an extraordinary corporate transaction, such as a merger, reorganization or liquidation, sale of a material amount of assets of the Issuer or its subsidiaries, or other transactions which might have the effect of causing the Common Stock to become eligible for termination of registration under Section 12(g) of the Act. The Filing Parties also retain the right to change their investment intent at any time, to acquire additional shares of Common Stock or other securities of the Issuer from time to time, or to sell or otherwise dispose of all or part of the Common Stock beneficially owned by them (or any shares of Common Stock into which such securities are converted) in any manner permitted by law. The Filing Parties may engage from time to time in ordinary course transactions with financial institutions with respect to the securities described herein.	2026-09-04
EMPD	Empery Digital Inc.	4	Item 4 is hereby amended to add the following: On August 28, 2026, the Court issued a memorandum opinion (the "Decision") in connection with the litigation initiated by the Complaint (the "Action"). The Decision addressed ATG Fund's claims that the Issuer's Board breached the Bylaws and breached its fiduciary duty in rejecting ATG Fund's Nomination Notice. In the Decision, the Court held that the Board "lacked contractual grounds to reject the Nomination Notice" and breached the Bylaws when it rejected ATG Fund's Nomination Notice. The Court also found that "the Board's reject[ion] [of] the Nomination Notice was inequitable and constituted a breach of the directors' fiduciary duties." The Decision expressly stated that "ATG [Fund]'s Nomination Notice is valid. ATG [Fund]'s nominees may stand for election at Empery's annual meeting." During the Action, the Defendants asserted that ATG Fund was required to disclose (a) a short position it held in certain Bitcoin ETFs (the "Bitcoin Short"), and (b) information concerning another stockholder, Tice Brown, as an alleged "participant" in ATG Fund's proxy campaign, in the Nomination Notice. The Defendants also asserted that ATG Fund was required to disclose the Bitcoin Short on its Schedule 13D filed on January 26, 2026, because ATG Fund stated that it might "engag[e] in short selling of or any hedging or similar transaction with respect to the Shares." The Court found that disclosure of the Bitcoin Short is not required under the Bylaws and that "ATG [Fund] could not fairly be expected to guess that the Board would interpret the Bylaws to require the disclosure of a Bitcoin short position." The Court held that the Defendants actions "reflect[] a misunderstanding of not only basic contract interpretation, but also the purpose advance notice bylaws serve under Delaware law." We believe that the Defendant's assertion that ATG Fund was required to disclose the Bitcoin Short on its Schedule 13D filing is also baseless, and that the January 26 Schedule 13D is accurate as the reference to "Shares," as defined therein, is to the Issuer's common stock and does not refer to hedging transactions in Bitcoin ETFs. As the Decision notes, ATG Fund previously held the Bitcoin Short. Given the Issuer's operational shift, ATG Fund has since closed out the Bitcoin Shorts and, as of the date hereof, no longer holds any short positions in Bitcoin ETFs. For the avoidance of doubt, other than its previously disclosed brief short sale of February 2026 call options, ATG Fund has never held short positions in any securities of the Issuer. In its post-trial brief, the Issuer asserted new allegations that Mr. Brown was a member of a "group" for the purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, and/or had agreements, arrangement or understandings with respect to the Issuer with ATG Fund. In the Decision, the Court found that "Mr. Brown is not a participant in ATG [Fund's] solicitation" and that ATG Fund was not required to include information concerning Mr. Brown in the Nomination Notice. The Court did not reach a decision regarding the Issuer's other claims regarding Mr. Brown raised in the post-trial brief. ATG Fund vigorously disputes these allegations. The foregoing description of the Decision does not purport to be complete and is qualified in its entirety by reference to the full text of the Decision, a copy of which is attached hereto as Exhibit 99.1 and incorporated herein by reference.	2026-09-03
RNW	ReNew Energy Global plc	4	This Amendment amends and supplements Item 4 of the Original Schedule 13D by adding the following: Transaction Agreement On August 11, 2026, the Issuer and a consortium comprising CPP Investments and the founder, Chairman and CEO of the Issuer, Mr. Sumant Sinha (together with CPP Investments, the "Consortium") entered into a Transaction Agreement (the "Transaction Agreement"). Under the terms of the Transaction Agreement, each Share of the Issuer that is not held by the Consortium and their respective affiliates, not held as a treasury share by the Issuer and not a Rollover Share (as defined below) will be transferred to CPP Investments, for cash consideration of US$7.02 per share, without interest and subject to applicable withholding taxes (the "Consideration"), to be implemented by means of a scheme of arrangement sanctioned by the High Court of Justice of England and Wales (the "Court") under Part 26 of the U.K. Companies Act 2006 (the "Scheme" and together with related transactions contemplated by the Transaction Agreement, the "Transaction"). Rather than receiving the Consideration in cash, each shareholder of the Issuer (other than any shareholder residing in India, who may not elect to participate in the Rollover as defined below) may elect to retain all of its shares of the Issuer, which will remain outstanding following the Scheme and in respect of which no Consideration or other distributions will be paid (a "Rollover", the shares so retained (and subject to the cutbacks described in the Transaction Agreement), the "Rollover Shares", and any Issuer shareholder holding any Rollover Shares, a "Rollover Shareholder"). Irrevocable Undertaking In connection with the Transaction, JERA Power RN B.V. ("JERA Power") has delivered an irrevocable undertaking in favor of the Consortium (the "Irrevocable Undertaking"). Pursuant to the Irrevocable Undertaking, JERA Power undertakes, among other things, to: (i) exercise (or procure the exercise of) all voting rights attaching to its Shares in favor of the Scheme, the Transaction and the related resolutions (and against any resolution to adjourn the relevant shareholder meetings, amend the Scheme, or which is likely to result in a condition of the Scheme not being fulfilled, impede or frustrate the Scheme, or prevent the Scheme from becoming effective); (ii) if the Transaction is implemented by way of a takeover offer, accept that offer in respect of its Shares; (iii) elect to participate in the Rollover in respect of all of its Shares; (iv) refrain from disposing of, or dealing in, its Shares, from acquiring further securities in the Issuer, from entering into third-party arrangements relating to its Shares and from taking any action that would restrict its ability to control the exercise of rights attaching to its Shares, in each case, other than pursuant to the Transaction; and (v) cooperate in the implementation of the Reorganization of the Issuer (as defined below) to be undertaken after the Effective Time of the Scheme (as defined below) and enter into the related Reorganization Deed (as defined below) and the Shareholders' Agreement (as defined below) to be entered into in connection with the Transaction, and provide reasonable cooperation in connection with obtaining required regulatory clearances (subject to customary confidentiality and privilege carve-outs). The Irrevocable Undertaking will lapse in specified circumstances, including if the Transaction Agreement is terminated, if the Scheme lapses or is withdrawn, if the Scheme is not effective (or the offer is not unconditional) by the specified long-stop time, or if a competing offer for the entire issued and to-be-issued share capital of the Issuer becomes effective or is declared unconditional. The foregoing description of the Irrevocable Undertaking does not purport to be complete and is qualified in its entirety by reference to the full text of the Irrevocable Undertaking, a copy of which is filed as Exhibit 99.8 to this Schedule 13D and is incorporated herein by reference. Pursuant to Section 13(d) of the Act, by virtue of the Irrevocable Undertaking described in this Schedule 13D, the Consortium may be deemed to be a member of a "group" with JERA Power. However, the Reporting Persons expressly disclaim beneficial ownership of the Shares beneficially owned by the Consortium, their affiliates or any other reporting person(s). Neither the filing of this Schedule 13D nor any of its contents shall be deemed to constitute an admission that the Reporting Persons beneficially own any Shares that are beneficially owned by the Consortium, their affiliates or any other reporting person(s). The Reporting Persons are only responsible for the information contained in this Schedule 13D and assume no responsibility for information contained in any other Schedule 13D filed by the Consortium, their affiliates or any other reporting person(s). Reorganization and Form of Reorganization Deed Concurrently with the execution of the Transaction Agreement, the Consortium has agreed with JERA Power the form of the Reorganization Deed and the form of the steps plan attached thereto (the "Reorganization Deed"). The Reorganization Deed, which will come into effect at the time at which an order of the Court sanctioning the Scheme is delivered to the Registrar of Companies (the "Effective Time", and the date on which the Effective Time occurs, the "Effective Date"), is the legal framework agreement that will bind the Consortium and Rollover Shareholders to the legal steps (the "Reorganization Steps") that will be undertaken after the Effective Time to effect a reorganization of the Issuer and its subsidiaries (the "Reorganization"), the result of which will be that all shareholders of the Issuer at the Effective Time will become direct shareholders of ReNew Private Limited, a wholly-owned subsidiary of the Issuer ("RPL"). The Reorganization Steps include the below steps, to occur in chronological order: 1. Constitutional Amendments. Once consummation of the Transaction has taken place, the share capital of the Issuer, which is currently comprised of four share classes, will be harmonized into a single class of ordinary shares with pari passu voting and economic rights. 2. The 'Re-Domicile'. Once the Issuer has been re-registered as a private company after consummation of the Transaction, it will transfer at fair market value (which, absent any significant delay between consummation of the Transaction and the re-domicile, is expected to be equivalent to the valuation considered for the purpose of the Transaction) its shares in RPL to each of the Issuer's shareholders on a pro rata basis (based on economic, rather than voting rights), which will have the effect of moving their shareholding to RPL directly. The consideration payable by each shareholder of the Issuer for the transfer of the relevant RPL shares to that shareholder will be left outstanding as a debt owed by that shareholder to the Issuer (the "Consideration Debt"). The Issuer will then immediately declare a distribution to each shareholder of an amount equal to that shareholder's Consideration Debt, and the amount owed by the Issuer to the shareholder under that distribution will be set off against the Consideration Debt so that the two amounts cancel out and no shareholder (nor the Issuer) is required to make a cash payment. The description of the Reorganization and the form of the Reorganization Deed contained in this Item 4 is not intended to be complete. A more detailed description of the Reorganization and the Reorganization Deed will be provided in the Scheme Circular, and a copy of the Reorganization Deed will be attached as an exhibit thereto. Form of the Shareholders' Agreement Concurrently with the execution of the Transaction Agreement, the Consortium has also agreed to a form of shareholders' agreement, which is expected to be entered into at the Effective Time (the "Shareholders' Agreement") by and among the Consortium and certain other continuing shareholders of the Issuer (and the applicable affiliates of the foregoing) that will hold the Rollover Shares (collectively, the "Investors"). The Shareholders' Agreement will govern the ownership and control of the Issuer from and after the Effective Time until the completion of the Reorganization, and RPL, the primary operating subsidiary of the Issuer, from and after the completion of the Reorganization, and will contain, among others, the following material terms (any reference to RPL below is also a reference to the Issuer for the period from and after the Effective Time until the completion of the Reorganization): Governance o Director Appointment Rights: The board of directors of the Issuer (the "Board") and, following completion of the Reorganization Steps, RPL will consist of the number of directors appointed in accordance with the following provisions: (i) the Investor who holds (A) an aggregate ownership interest in RPL or Issuer (as applicable) of more than 50% (on a non-diluted basis), or (B) an aggregate ownership interest of 40% or more and is the single largest ownership interest in RPL or Issuer (as applicable) (on a non-diluted basis) (in either case, the "Controlling Investor") will be entitled to appoint an unlimited number of directors to the Board; (ii) each Investor holding 10% or more of the ownership interest in RPL (on a non-diluted basis) (to the extent not already entitled to appoint an unlimited number of directors under the preceding clause) will be entitled to appoint one director to the Board; (iii) an Investor holding less than 10% of the ownership interest in RPL (on a non-diluted basis) will not hold any director appointment rights; (iv) Mr. Sinha will be entitled to serve as a director on the Board, subject to certain sunset provisions set forth in the Shareholders' Agreement; and (v) any Investor holding 5% or more of the ownership interest in RPL (on a non-diluted basis) will be entitled to appoint a non-voting observer to the Board. Reserved Matters o The Shareholders' Agreement contains customary "reserved matters" provisions, which require the approval of at least 87.6% of the ownership interests in RPL (on a non-diluted basis), in some cases, and at least 95% of the ownership interests in RPL (on a non-diluted basis), in other cases, prior to RPL taking certain specified actions set forth in the Shareholders' Agreement. Transfer Restrictions o The Shareholders' Agreement contains a three-year lock-up binding on all Investors (other than the Controlling Investor), as well as a right of first offer in favor of the Controlling Investor and tag/drag-along rights in respect of transfers by the Controlling Investor. Indian IPO o Within 12 months following the Effective Time, the Board will establish a "Strategic Options Committee" comprised of at least five members, to include (i) Mr. Sinha (for as long as he remains a director), (ii) one member appointed by each Investor holding 12.5% or more of the ownership interests in RPL (on a non-diluted basis) and (iii) a remaining number, sufficient to comprise a majority, appointed by the Controlling Investor, to oversee preparation for the admission of RPL's ordinary shares to a recognized stock exchange. The description of the form of the Shareholders' Agreement contained in this Item 4 is not intended to be complete. A more detailed description of the form of the Shareholders' Agreement will be provided in the Scheme Circular, and a copy of the form of the Shareholders' Agreement will be attached as an exhibit thereto. Other than as described in this Schedule 13D, the Reporting Persons have no plans or proposals of the type referred to in clauses (a) through (j) of Item 4 of Schedule 13D that relate to their investment in the Issuer, although they and their affiliates reserve the right to formulate such plans or proposals in the future. If the Transaction does not proceed, the Reporting Persons will continue to regularly review and assess their investment in the Issuer and depending on market conditions, general economic and industry conditions, the Issuer's business and financial condition and/or other relevant factors, the Reporting Persons may or may not: (i) purchase or sell the Shares or other securities of the Issuer in the future on the open market or in private transactions, or (ii) determine, from time to time, to engage in any of the events set forth in clauses (a) through (j) of Item 4 of Schedule 13D.	2026-08-11
EVGN	EVOGENE LTD.	4	Item 4 of the Schedule 13D is hereby amended to add the following at the end thereof: On August 28, 2026, the Reporting Persons disseminated a communication to shareholders entitled "Response of L.I.A. Pure Capital and Invest-Pro to Evogene's August 25, 2026 Press Release." In such communication, the Reporting Persons expressed their views regarding the Issuer's performance, governance and board composition and encouraged shareholders to support the Reporting Persons' nominees for election to the Issuer's board of directors at the Issuer's upcoming annual meeting of shareholders. A copy of such communication is attached hereto as Exhibit 8 and is incorporated herein by reference. .	2026-08-28
LBRDA	Liberty Broadband Corporation	4	The information contained in Item 4 of the Schedule 13D is hereby amended to delete last three paragraphs thereof and supplemented to include the following information: As previously disclosed by the Issuer, on November 12, 2024, the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement") with Charter Communications, Inc. ("Charter"), Fusion Merger Sub 1, LLC, a Delaware limited liability company and wholly owned subsidiary of Charter ("Merger LLC"), and Fusion Merger Sub 2, Inc., a Delaware corporation and wholly owned subsidiary of Merger LLC ("Merger Sub"), whereby, subject to the terms thereof, (i) Merger Sub would merge with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as the surviving corporation and a wholly owned subsidiary of Merger LLC, and (ii) the Merger would be immediately followed by a merger of, the Issuer, as such surviving corporation, with and into Merger LLC (the "Upstream Merger", and together with the Merger, the "Combination"), with Merger LLC surviving the Upstream Merger as the surviving company and a wholly owned subsidiary of Charter. On August 19, 2026, the transactions contemplated by Merger Agreement, including the Combination, were completed, and each share of Series B common stock and the Issuer's Series A common stock, par value $0.01 per share, and the Issuer's Series C common stock, par value $0.01 per share, was automatically converted into 0.2360 of a validly issued, fully paid and nonassessable share of Charter's Class A common stock, par value $0.001 per share, except that cash (without interest) was paid in lieu of fractional shares, and accordingly as a result of the completion of the Merger the Reporting Person disposed of all of the shares of Series B common stock beneficially owned by the Reporting Person and ceased to be the beneficial owner of any shares of Series B common stock.	2026-08-20
AMRX	Amneal Pharmaceuticals, Inc.	3	This Amendment No. 7 to Schedule 13D (this "Amendment No. 7") amends and supplements the Schedule 13D filed with the SEC on July 9, 2018 (the "Initial 13D" and, as amended and supplemented through the date of this Amendment No. 7, the "Schedule 13D"), by the Reporting Person relating to Class A Common Stock of the Issuer. Capitalized terms used but not defined in this Amendment No. 7 shall have the meanings set forth in the Schedule 13D.	2026-08-12
CHTR	CHARTER COMMUNICATIONS, INC. /MO/	3	The information with respect to the consummation of the Transactions and the Ancillary Agreements entered into in connection therewith, as well as the continued Suspension of the Share Repurchases set forth in Items 5(c) and 6 is incorporated herein by reference to the extent responsive to this Item 4.	2026-08-21
INVX	Innovex International, Inc.	3	Item 4 of the Schedule 13D is hereby amended and supplemented by the addition of the following: Underwriting Agreement On August 6, 2026, the Issuer entered into an Underwriting Agreement (the "Underwriting Agreement") with Intervale Capital Fund II, L.P., Intervale Capital Fund II-A, L.P., Intervale Capital Fund III, L.P., Amberjack Capital Fund II, L.P., Innovex Co-Invest Fund, L.P., Innovex Co-Invest Fund II, L.P., (collectively, the "Seller Stockholders") and Barclays Capital Inc., as underwriter (the "Underwriter"), relating to the offer and sale by the Selling Stockholders of 5,000,000 shares of common stock, par value $0.01 per share, of the Issuer (the "Common Stock"), at a price to the Underwriter of $28.71 per share (the "Offering"). Amberjack Capital Fund II, L.P. sold 3,706,801 shares of Common Stock to the Underwriter. Innovex Co-Invest Fund II, L.P. sold 865,508 shares of Common Stock to the Underwriter. Innovex Co-Invest Fund, L.P. sold 205,126 shares of Common Stock to the Underwriter. Intervale Capital Fund II, L.P. sold 176,944 shares of Common Stock to the Underwriter. Intervale Capital Fund II-A, L.P. sold 88 shares of Common Stock to the Underwriter. Intervale Capital Fund III, L.P. sold 45,533 shares of Common Stock to the Underwriter. The Offering closed on August 10, 2026. The Underwriting Agreement contains customary representations and warranties, agreements and obligations, closing conditions and termination provisions. The foregoing description of the Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Underwriting Agreement, which is incorporated by reference as Exhibit 99.1 and is incorporated herein by reference. Lock-up Agreement On August 6, 2026, the Underwriter entered into a lock-up agreement with the Selling Stockholders (the "Lockup Agreement"). Under the Lockup-Agreement, the Selling Stockholders agreed to not and not to cause any affiliates to, during the period beginning on the date of the Lock-up Agreement and ending at the close of business 45 days after the date of the final prospectus relating the Offering, to transfer any Common Stock or any shares underlying such Common Stock without the prior written consent of the Underwriter, subject to certain exceptions. The foregoing description of the Lock-Up Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Form of Lock-Up Agreement, which is incorporated by reference as Exhibit 99.2 and is incorporated herein by reference.	2026-08-13
GSHD	GOOSEHEAD INSURANCE INC -A	3	The Reporting Persons acquired, and presently hold, Class A Common Stock and Class B Common Stock for investment purposes. Each Reporting Person has signed and is a party to the Voting Agreements described in Item 2 above. Except as otherwise described herein and Rule 10b5-1 Trading Plans, none of the Reporting Persons currently has any plans or proposals that would result in or relate to any of the transactions or changes listed in Items 4(a) through 4(j) of Schedule 13D. However, as part of their ongoing evaluation of their investment and investment alternatives, the Reporting Persons may consider such matters and, subject to applicable law, may formulate a plan with respect to such matters or make formal proposals to the board of directors of the Issuer, other stockholders of the Issuer or other third parties regarding such matters. The Reporting Persons reserve the right to acquire additional securities of the Issuer in the open markets, in privately negotiated transactions (which may be with the Issuer or with third parties) or otherwise, to dispose of all or a portion of their holdings of securities of the Issuer or to change their intention with respect to any or all of the matters referred to in this Item 4.	2026-08-24
CISS	C3is Inc.	3	The Reporting Person involved in the securities described in this Schedule 13D in connection with the Spin-Off Distribution, and intends to review its investment in the Issuer on a continuing basis. The Reporting Person may from time to time acquire additional securities of the Issuer, or retain or sell all or portion of the shares then held by the Reporting Person, in the open market, block trades, underwritten public offerings or privately negotiated transactions. Any actions the Reporting Person might undertake with respect to its investment in the Issuer may be made at any time and from time to time and will be dependent upon the Reporting Person's review of numerous factors, including, but not limited to: ongoing evaluation of the Issuer's business, financial condition, operations, prospects and strategic alternatives; price levels of the Issuer's securities; general market, industry and economic conditions; the relative attractiveness of alternative business and investment opportunities; tax considerations; liquidity of the Issuer's securities; and other factors and future developments. Mr. Vafias serves as the Non-Executive Chairman of the Issuer and John Kostoyannis and George Xiradakis each serve as a director of the Issuer, other shareholders of the Issuer and other relevant parties, which discussions may include matters ranging from the operations and conduct of the Issuer's business to considering or exploring extraordinary corporate transactions including the events listed in Item 4(a) through 4(j) of Schedue 13D. In connection with these discussions, the Reporting Person may, either directly or through one or more affiliates, determine to take any available course of action or to take no course of action and may at any time and from time to time take steps to further or implement such course of action, including any of the events listed in Item 4(a) through 4(j) of Schedule 13D. Any action or actions the Reporting Person may undertake with respect to its investment in the Issuer or the operations and conduct of the Issuer's business will be dependent upon the Reporting Person's review of numerous factors, including those listed above, and the Reporting Person specifically reserves the right to change its intentions, or to formulate plans and proposals, with respect to any or all of the matters described in this paragraph, subject to applicable law and regulations.	2026-08-28
BNBX	BNB PLUS CORP.	3	Item 4 of the Schedule 13D is hereby amended to add the following: Strategic Review Update; Relationship to GlobalStake. The strategic review of the Issuer's businesses being conducted by an affiliate of the Reporting Persons has been substantially undertaken, and the Board has considered and, in certain cases, begun to implement recommendations arising from that review. Specifically, an existing asset management agreement has been terminated, resulting in significant net savings for the Issuer. In addition, the review suggested the addition to the Board of members with digital asset and related industry experience. Richard Shorten indirectly controls GlobalStake, the entity engaged by the Issuer to conduct the strategic review, and serves as the engagement leader for GlobalStake's engagement by the Issuer. The Reporting Persons expect that additional recommendations arising from the strategic review may be considered and, if approved by the Board, implemented in the future. Certain recommendations arising from the strategic review may involve transactions in which GlobalStake or its affiliates would be a principal party. Appointment of Richard Shorten to the Board. Richard Shorten, a Reporting Person, was appointed to serve as a member (and new Chairman) of the Board, effective September 3, 2026. Prior to such appointment, Richard Shorten was interviewed by the Issuer's nominating committee and by the Board. Following that process, the committee recommended, and the Board independently determined, to appoint Richard Shorten to the Board. Recommendation of Additional Director Candidates; Resulting Board Composition. In connection with the Board's consideration of candidates, the Reporting Persons recommended two individuals, Lok Lee and Todd Larsen, as potential director candidates. The Issuer's nominating committee and the Board interviewed each candidate, independently evaluated his qualifications, and thereafter independently determined to appoint each such individual to the Board, effective September 3, 2026. As of the date of this Amendment, the Board consists of five members, of whom three - Richard Shorten, Todd Larsen and Lok Lee - were appointed following the Reporting Persons' recommendation. The Reporting Persons do not have any agreement, arrangement, or understanding - written or oral, formal or informal - with any candidate appointed or nominated to the Board regarding such person's service on the Board, the exercise of such person's fiduciary duties, or the acquisition, holding, voting, or disposition of any securities of the Issuer. Conflicts Process. The Reporting Persons have advised the Issuer that Richard Shorten will recuse himself from Board deliberations and voting with respect to the engagement of GlobalStake and with respect to any transaction in which GlobalStake may have an interest or otherwise as may be required by applicable law. No Agreements Regarding Board Service or Securities. The Reporting Persons have no agreement, arrangement, or understanding with the Issuer with respect to the appointment of Richard Shorten or of any other individual to the Board, and have no right to designate any director of the Issuer. The Reporting Persons have no agreement, arrangement, or understanding of any kind with the individuals recommended as director candidates, with respect to (i) the acquisition, holding, voting, or disposition of any securities of the Issuer, (ii) such individuals' service on, or conduct as members of, the Board, or (iii) the exercise of such individuals' fiduciary duties. Neither of such individuals is employed by, or receives any compensation, indemnification, or reimbursement from, the Reporting Persons or any of their affiliates with respect to service on the Board and, to the knowledge of the Reporting Persons, neither such individual owns any securities of the Issuer. Disclaimer of Group Status. The Reporting Persons expressly disclaim membership in any 'group' within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, or Rule 13d-5(b) thereunder, with (i) the Issuer, (ii) any other stockholder of the Issuer, or (iii) any member of the Board, including any director recommended by the Reporting Persons. Each member of the Board exercises independent judgment and owes fiduciary duties to the Issuer and all of its stockholders. Continuing Reservation of Rights. The Reporting Persons intend to continue to engage with the Issuer's Board and management regarding the strategic direction of the Issuer, the implementation of recommendations arising from the strategic review, and other matters affecting shareholder value. The Reporting Persons intend to review their investment in the Issuer on a continuing basis and may, at any time and from time to time, engage in discussions with members of the Board, management of the Issuer, other stockholders, potential investors, strategic partners and other interested parties regarding the Issuer's business, operations, management, governance, strategy, capitalization, capital allocation, financial condition and prospects. Depending upon various factors, including the Issuer's business and financial position and prospects, the price level of the Common Stock, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may, at any time and from time to time, review or reconsider their position, change their purpose, formulate plans or proposals with respect thereto, or take any other action with respect to their investment in the Issuer as they deem appropriate, including acquiring additional securities, disposing of securities, proposing or considering changes in the Issuer's operations, management, Board composition, governance, capitalization or strategic direction, or considering or proposing one or more of the actions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.	2026-09-04
VNOM	Viper Energy, Inc.	3	Item 4 of the Schedule 13D is hereby amended and supplemented as follows: Closing of the Purchase Agreement On September 1, 2026, the previously disclosed Purchase Agreement closed. As a result, the Reporting Persons acquired an aggregate of 3,815,459 OpCo units and an equivalent number of shares of the Issuer's Class B Common Stock.	2026-09-03
MBX	MBX BIOSCIENCES, INC.	3	The Reporting Persons from time to time intend to review their investment in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the Issuer's Shares in particular, as well as other developments and other investment opportunities. Based upon such review, the Reporting Persons will take such actions in the future as the Reporting Persons may deem appropriate in light of the circumstances existing from time to time. If the Reporting Persons believe that further investment in the Issuer is attractive, whether because of the market price of Shares or otherwise, they may acquire Shares or other securities of the Issuer either in the open market or in privately negotiated transactions. Similarly, depending on market and other factors, the Reporting Persons may determine to dispose of some or all of the Shares currently owned by the Reporting Persons or otherwise acquired by the Reporting Persons either in the open market or in privately negotiated transactions. Except as set forth in this Schedule 13D, the Reporting Persons have not formulated any plans or proposals which relate to or would result in: (a) the acquisition by any person of additional securities of the Issuer or the disposition of securities of the Issuer, (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries, (c) a sale or transfer of a material amount of the assets of the Issuer or any of its subsidiaries, (d) any change in the present Board of Directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board, (e) any material change in the Issuer's capitalization or dividend policy of the Issuer, (f) any other material change in the Issuer's business or corporate structure, (g) any change in the Issuer's charter or bylaws or other instrument corresponding thereto or other action which may impede the acquisition of control of the Issuer by any person, (h) causing a class of the Issuer's securities to be deregistered or delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association, (i) a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act or (j) any action similar to any of those enumerated above.	2026-08-14
WLDS	Wearable Devices Ltd.	3	Item 4 of the Schedule 13D is hereby amended to add the following at the end thereof: On August 7, 2026, the Reporting Persons entered into a Cooperation Agreement (the "Cooperation Agreement") with the Issuer to resolve the matters raised in the Reporting Persons' demand letter requesting that the Issuer convene a special general meeting of shareholders (the "Demand Letter") and the legal proceedings commenced by the Reporting Persons in connection with the Issuer's previously announced private placement (the "Court Proceedings"). Pursuant to the Cooperation Agreement, effective three business days following the dismissal of the legal proceedings, two existing directors of the Issuer will resign from the Issuer's board of directors and the Issuer will take the necessary actions to appoint four new directors to the Issuer's board of directors. Following such appointments and resignations, the Issuer's board of directors will consist of seven members. In addition, pursuant to the Cooperation Agreement, the Reporting Persons agreed to irrevocably withdraw their Demand Letter and cease all efforts in furtherance thereof, and the parties agreed that the Court Proceedings would be dismissed with no order as to costs. On August 10, 2026, following the filing of a joint notice and motion for termination of the Court Proceedings, the Court dismissed the Court Proceedings with no order as to costs. Moreover, pursuant to the Cooperation Agreement, each Reporting Person agreed, for a period of two years following the execution of the Cooperation Agreement, to cause its affiliates to refrain from taking any direct or indirect action to knowingly hinder, interfere with, change or influence the Issuer's or any of its subsidiaries' corporate governance, operations, management or board composition, except as expressly permitted by the Cooperation Agreement, with the prior written consent of the Issuer or in connection with voting its shares at meetings of the Issuer's shareholders. The Cooperation Agreement also contains certain mutual release and non-disparagement provisions applicable to the parties. The releases do not include rights or claims to enforce the Cooperation Agreement or claims relating to fraud, malicious actions or willful misconduct. In connection with the Cooperation Agreement, on August 7, 2026, J.B.D Innovation Ltd. entered into a Side Letter with the Issuer pursuant to which it committed, for a period of 24 months, to provide financing to the Issuer if the Issuer's board of directors determines in good faith that the Issuer does not have sufficient financial resources to fund its operations for the following 24 months. If such condition is satisfied, J.B.D Innovation Ltd. has agreed to provide debt financing in an aggregate principal amount of not less than $12.0 million for the purpose of funding the Issuer's ongoing current business operations. Such financing would be structured as convertible debt and would be subject to negotiation and execution of definitive financing documentation. The foregoing description of the Cooperation Agreement and the Side Letter is qualified in its entirety by reference to the full text thereof, copies of which are filed as exhibits hereto and incorporated herein by reference.	2026-08-14
ETOR	eToro Group Ltd.	3	The information set forth in Item 4 of the Original 13D is incorporated herein by reference.	2026-09-04
TALK	Talkspace, Inc.	3	Item 4 of the Existing Schedule 13D is hereby amended and supplemented by adding the following: On August 17, 2026, the merger (the "Merger") contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated March 9, 2026, by and among the Issuer, Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub") was consummated. Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer, and the Issuer continued as the surviving corporation as an indirect wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each outstanding share of Common Stock (other than shares of Company Common Stock to be canceled pursuant to the Merger Agreement and shares with respect to which appraisal rights were properly exercised and not withdrawn under Delaware law) was automatically converted into the right to receive $5.25 in cash, without interest (the "Merger Consideration"). In addition, as of the Effective Time, each stock option granted under the Issuer's equity incentive plans (a "Stock Option") that was vested as of the Effective Time (each, a "Vested Stock Option") was cancelled and converted into the right to receive an amount in cash equal to the excess, if any, of (i) the Merger Consideration over (ii) the per share exercise price of such Vested Stock Option. Each restricted stock unit granted under the Issuer's equity incentive plans ("RSU") that was vested, but not yet settled, as of the Effective Time, was cancelled and converted into the right to receive the Merger Consideration for each RSU. Immediately prior to the Effective Time, each of the Issuer's directors, including Mr. Shachar, resigned from, and ceased serving on, the Issuer's board of directors. Following the Merger, the Reporting Persons no longer beneficially own any securities of the Issuer, nor do they have sole or shared power to vote, direct the vote, dispose or direct the disposition of, any securities of the Issuer. The Common Stock will no longer be listed on Nasdaq and will be deregistered under Section 12(b) of the Exchange Act.	2026-08-17
UEIC	UNIVERSAL ELECTRONICS INC	3	Item 4 is hereby amended to add the following: The sales reported herein were undertaken for the purpose of offsetting certain tax liabilities of the Reporting Persons.	2026-09-04
ESTC	Elastic N.V.	3	The Reporting Person acquired shares of Elastic NV as part of its investment strategy, which includes considering the clarity and robustness of the issuer's long-term strategy; the functioning and calibre of governance structures and effective leadership; the financial strength and performance of issuers and the fair valuation of underlying securities; and financially-material sustainability risks & opportunities. The Reporting Person is therefore actively engaging with the Issuer to discuss and promote initiatives that align with these business practices. This engagement is part of the Reporting Person's broader strategy to support companies in enhancing their approach, thereby potentially improving long-term shareholder value. As such, the Reporting Person may seek to influence the Issuer's policies and practices through discussions with the Boards and management of the companies in which we invest. The Reporting Person does not currently have any plans or proposals that would result in a change in control of the Issuer, nor does it intend to acquire additional shares for the purpose of gaining control. However, the Reporting Person reserves the right to change its intentions and take any actions that it deems appropriate in light of its ongoing engagement and evaluation of the Issuer's policies and practices.	2026-09-02
GAP	The Gap, Inc.	3	This Statement is filed on behalf of the Reporting Person to update the beneficial ownership information from that reported in the Schedule 13D. The Reporting Person reviews their investments in the Issuer on a continuing basis and may, at any time, consistent with the obligations of the Reporting Person under the federal securities laws, determine to increase or decrease their respective ownership of shares of the Issuer's Common Stock through purchases or sales of such Common Stock of the Issuer in the open market, in privately negotiated transactions or by gift or other transfers as circumstances dictate. From time to time, the Reporting Person has transferred shares to various entities controlled by him, disposed of certain shares to third parties by gift and sold shares of Issuer Common Stock in the open market and in privately negotiated transactions, and the Reporting Person may do so in the future. The review of his investment in the Issuer by the Reporting Person will depend on various factors, including the Issuer's business prospects, other developments concerning the Issuer, alternative investment opportunities, general economic conditions, money and stock market conditions, and any other facts and circumstances which may become known to the Reporting Person regarding his investment in the Issuer. At the time of filing this Statement, the Reporting Person has no plans to sell or to purchase additional shares of Common Stock of the Issuer in the open market or in privately negotiated transactions but may engage in such transactions in the future. At the time of the filing of this Statement, except as disclosed herein, the Reporting Person has no present plans or proposals in his capacity as a stockholder which relate to or would result in (i) the acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer, (ii) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries, (iii) a sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries, (iv) any change in the Board of Directors or management of the Issuer or any of its subsidiaries, (v) any material change in the present capitalization or dividend policy of the Issuer, (vi) any other material change in the Issuer's business or corporate structure; (vii) changes in the Issuer's charter or bylaws or other actions which may impede the acquisition of control of the Issuer by any person, (viii) causing a class of securities of the Issuer to be delisted from a national securities exchange or cease to be quoted in an inter-dealer quotation system of a registered national securities association, (ix) a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act or (x) any action similar to any of those described above. However, because the Reporting Person is a member of the Board of Directors of the Issuer, he may, from time to time, be involved in discussions which relate to one or more of the matters described in this Item 4. The Reporting Person disclaims any obligation to report on any plans or proposals with respect to the matters described in this Item 4 that develop or occur as a result of his role as a director of the Issuer and participation in decisions regarding the Issuer's actions.	2026-09-04
QSR	Restaurant Brands International Inc.	3	Item 4 of Schedule 13D is hereby amended to add the following language: As noted above, 3G RBH delivered to RBI LP an exchange notice to exchange 2,784,549 Exchangeable Units held by 3G RBH. The exchange notice became irrevocable on August 10, 2026 with respect to 2,784,549 Exchangeable Units. As announced by the Issuer on August 10, 2026, upon receipt of the exchange notice, the Issuer, in its capacity as general partner of RBI LP, elected to have RBI LP satisfy the 2026 Exchange by repurchasing 2,784,549 Exchangeable Units for cash. The 2026 Exchange will be effected as of the close of business on August 31, 2026. The Reporting Persons continue to hold 94,373,170 Exchangeable Units, for which they have not submitted any exchange notice. Except as set forth in this Schedule 13D and in connection with the Transactions and the other transactions discussed herein, the Reporting Persons have no plan or proposals that relates to or would result in any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.	2026-08-14

代码	申报人	类型	申报日期	持股数	持股比例
HZO	American Century Investment Management, Inc.	13G/A	2026-09-04	943K	4.3%
ALPS ETF Trust	TRUIST FINANCIAL CORP	13G/A	2026-09-04	63K	5.6%
ALPS ETF Trust	TRUIST FINANCIAL CORP	13G/A	2026-09-04	60K	8.8%
Themes ETF Trust	TRUIST FINANCIAL CORP	13G/A	2026-09-04	0	0.0%
JMM	SIT INVESTMENT ASSOCIATES INC	13G/A	2026-09-04	5.93M	62.6%
CABO	DAVENPORT & Co LLC	13G/A	2026-09-04	214K	3.8%
CNXU	Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund	13G/A	2026-09-04	4.31M	10.0%
AMG BBH Asset-Backed Credit Fund, LLC	BROWN BROTHERS HARRIMAN & CO	13D/A	2026-09-04	2.67M	63.4%
IPEX	KARPUS MANAGEMENT, INC.	13G/A	2026-09-04	0	0.0%
PGAC	KARPUS MANAGEMENT, INC.	13G/A	2026-09-04	820K	16.0%
RFAI	KARPUS MANAGEMENT, INC.	13G/A	2026-09-04	989K	24.8%
SSAC	KARPUS MANAGEMENT, INC.	13G/A	2026-09-04	1.20M	5.0%
YHNA	KARPUS MANAGEMENT, INC.	13G/A	2026-09-04	97K	2.3%
BACC	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	0	0.0%
CUB	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	0	0.0%
MOUNTAIN LAKE ACQUISITION CORP.	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	0	0.0%
ODYSSEUS (CAYMAN) LTD	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	0	0.0%
Presidio MidCo Inc.	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	0	0.0%
CHURCHILL CAPITAL CORP IX	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	0	0.0%
ALFUU	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	0	0.0%
SIMAU	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	0	0.0%
TMS	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	855K	1.6%
ADXN	Timothy Mark Dyer	13D/A	2026-09-04	19.17M	9.0%
GAP	Robert J. Fisher	13D/A	2026-09-04	45.62M	13.0%
GAP	John J. Fisher	13D/A	2026-09-04	45.80M	13.0%
RUM	Tether Global Investments Fund, S.I.C.A.F., S.A.	13D/A	2026-09-04	261.49M	50.3%
Presidio MidCo Inc.	MAGNETAR FINANCIAL LLC	13G/A	2026-09-04	0	0.0%
GRNT	GREP GP III, LLC	13D/A	2026-09-04	51.65M	39.2%
TREX	AllianceBernstein L.P.	13G/A	2026-09-04	202K	0.2%
UEIC	Ameriprise Financial, Inc.	13G/A	2026-09-04	1.70M	13.2%
CATX	Lantheus Holdings, Inc.	13D/A	2026-09-04	11.44M	10.0%
ETOR	Spark Capital II, L.P.	13D/A	2026-09-04	2K	0.0%
GPRK	Colden Investments S.A.	13D/A	2026-09-04	18.12M	27.9%
PAX	Capital Research Global Investors	13G/A	2026-09-04	0	0.0%
First Trust Exchange-Traded Fund V	First Trust Portfolios L.P.	13G/A	2026-09-04	1.45M	26.9%
First Trust Exchange-Traded Fund VI	First Trust Portfolios L.P.	13G/A	2026-09-04	19.58M	76.6%
First Trust Exchange-Traded Fund VI	First Trust Portfolios L.P.	13G/A	2026-09-04	994	0.0%
First Trust Exchange-Traded Fund VIII	First Trust Portfolios L.P.	13G/A	2026-09-04	2.15M	23.3%
First Trust Exchange-Traded Fund VIII	First Trust Portfolios L.P.	13G/A	2026-09-04	2.14M	34.3%
VanEck Emerging Markets High Yield Bond ETF	First Trust Portfolios L.P.	13G/A	2026-09-04	2.78M	10.7%
First Trust Exchange-Traded Fund VIII	First Trust Portfolios L.P.	13G/A	2026-09-04	58K	12.9%
MLR	Neuberger Berman Group LLC	13G/A	2026-09-04	1.14M	10.0%
AMSF	Neuberger Berman Group LLC	13G/A	2026-09-04	569	0.0%
BC Partners Lending Corp	First Trust Alternative Opportunities Fund	13G/A	2026-09-04	567K	14.6%
TCW SPECIALTY LENDING LLC	First Trust Alternative Opportunities Fund	13G/A	2026-09-04	2.30M	11.2%
BTCK	PenderFund Capital Management Ltd.	13G/A	2026-09-04	350K	2.9%
VBIO	3i, LP	13G/A	2026-09-04	133K	9.9%
BNBX	Comstock MultiChain Fund, L.P.	13D/A	2026-09-04	688K	9.9%
NPCE	First Light Asset Management, LLC	13G/A	2026-09-04	4.20M	12.3%
NVT	BlackRock, Inc.	13G/A	2026-09-04	17.17M	10.6%
LEU	BlackRock, Inc.	13G/A	2026-09-04	2.24M	11.6%
iShares GNMA Bond ETF	BlackRock, Inc.	13G/A	2026-09-04	1.03M	10.3%
LAZ	BlackRock, Inc.	13G/A	2026-09-04	10.87M	11.2%
LTH	BlackRock, Inc.	13G/A	2026-09-04	22.42M	10.0%
TENB	BlackRock, Inc.	13G/A	2026-09-04	19.33M	17.5%
THC	BlackRock, Inc.	13G/A	2026-09-04	8.08M	10.0%
WDAY	BlackRock, Inc.	13G/A	2026-09-04	19.67M	10.0%
BILL	BlackRock, Inc.	13G/A	2026-09-04	8.63M	10.1%
SMTC	BlackRock, Inc.	13G/A	2026-09-04	9.35M	10.0%
STRL	BlackRock, Inc.	13G/A	2026-09-04	3.09M	10.1%

代码

类型

申报日期

持股比例

HZO

13G/A

2026-09-04

4.3%

ALPS ETF Trust

13G/A

2026-09-04

5.6%